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Abstract 
A new series of chiral ferrosalen ligands was designed and synthesized. The 
special feature of the ferrosalen ligands is that the chirality originated from the 
planar chiral ferrocenyl structure. For most known salen ligands, chirality comes 
from central and axial chiral centers. The key building block for the construction 
of these ferrosalen ligands was synthesized stereoselectively by a chiral auxiliary 
approach. This approach does not consume any chiral material, and does not 
require chiral HPLC resolution. Using this method, nine ligands were prepared 
using ferrocene as the starting material. In addition, the steric hindrance was 
modulated by changing the cyclopentadienyl group to the more bulky 
pentamethylcyclopentadienyl- and pentaphenylcyclopentadienyl- groups. The 
structure of these ligands was established by 1H and 13C NMR. The structure of a 
ferrosalen-Cu (II) complex was determined by single crystal X-ray diffraction 
analysis.  
 All the chiral ferrosalen ligands were tested in catalytic asymmetric 
reactions including enantioselective carbonyl-ene reaction, enantioselective 
Strecker-type reaction and enantioselective silylcyanation. For the carbonyl-ene 
reaction, up to 99% yield and 29% enantiomeric excess (ee) were obtained using 
ligand-Co (III) as the catalysts; For the Strecker-type reaction, a maximum of 20% 
xx 
 
ee was obtained using ligand-AlCl as the catalyst; For the silylcyanation reaction, 
up to 99% yield and 26% ee were obtained using ligand-AlCl as the catalyst. 
   
1 
 
Chapter 1 
Introduction 
 This chapter includes an introduction and some background information for 
all the subsequent Chapters (Chapter 2, 3 and 4) of this dissertation. The 
compound numbers, equations, schemes, figures and tables are restricted to each 
Chapter and not continued from one Chapter to another.   
1.1 General Introduction 
 The synthesis of enantiopure compounds has become one of the most active 
areas of current chemical research. In nature, most biological molecules such as 
proteins and sugars are present in only one enantiopure form, which can 
distinguish the enantiomers of a chiral drug molecule. Different enantiomers of a 
given drug molecule can exhibit dramatically different bioactivities. The wrong 
enantiomer may be inactive, or even cause serious side effects. Of the 10 top-
selling drugs, nine have chiral active pharmaceutical ingredients (APIs) and six are 
single enantiomers.1 
The demand for efficient production of enantiopure chiral compounds 
continues to rise. The increasing trend has led to explosive interests in developing 
new stereoselective reactions (“asymmetric synthesis”), which is defined as the 
intentional construction of enantiomers of a given constitutional isomer by means 
of chemical reaction.2 There are three approaches to make enantiopure compounds: 
2 
 
(1) intramolecular chirality transfer: asymmetric control is achieved by an existing 
chiral unit from the substrate (Figure 1.1a); (2) intermolecular chirality transfer: 
chirality is induced by temporarily inserting a chiral-directing group into the 
original achiral substrate which is removed after synthesis (Figure 1.1b); (3) 
asymmetric catalysis: a chiral catalyst is used to induce the conversion of achiral 
substrates to chiral products (Figure 1.1c). Among the three approaches mentioned 
above, asymmetric catalysis is the preferred method.  
 
Figure 1.1: Methods of asymmetric synthesis 
 1.2 Asymmetric catalysis 
The advantage of asymmetric catalysis is that a small amounts of chiral 
catalyst produce chiral compounds in large quantity. This advantage can be 
evaluated with the chiral multiplication efficiency, ߠ (Equation 1.1). In theory, the 
efficiency of asymmetric catalysis can be ∞, while those methods using intra- and 
intermolecular chirality transfer are 0.2 The advantages of enantioselective 
3 
 
catalysis have made the method one of the most explored areas of chemistry in 
recent years. 
ߠ ൌ ሺmajor enantiomerሻ െ ሺminor enantiomerሻ chiral source  
Equation 1.1: Equation of chirality multiplication efficiency (ࣂ) 
Most catalysts for enantioselective reactions consist of two major 
components: metal catalytic center and chiral ligand. Catalytic activity is usually 
related to the metal catalyst (Figure 1.2). A catalytic cycle starts with bond 
activation of the substrate by coordination of the metal to the reacting site on the 
substrate (R1), which is usually followed by the attachment of the second reactant 
(R2). The catalytic cycle is finished by detachment of the metal catalyst to form 
product. Sometimes there might be an additional step to regenerate the catalyst.3 
 
Figure 1.2: General process of catalytic cycle    
 
4 
 
For a catalytic asymmetric reaction, enantioselectivity and reactivity are 
mainly modulated by the chiral ligands. The combined electronic and steric effects 
should maximize enantioselectivity and reactivity. Proper ligand must be chosen 
to achieve efficient intermolecular chirality transfer from the catalyst to the 
substrate, and make one of the enantiomeric products to form predominately.  
According to the rule proposed by Cahn, Ingold, and Prelog (the CIP rule), 
there are three types of chiralities: central, axial and planar.4 A chiral center is 
defined as an atom in a molecule that is bonded to four different chemical species, 
allowing for optical isomerism. Axial chirality is a special case of chirality in 
which a molecule possesses an axis as the chiral unit – the substituents is held in 
the way by the axis that is non- superposable with its mirror image. 2,2′-
bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) is a widely used example of a 
molecule with a chiral axis (Figure 1.3). Planar chirality is another type of 
stereoisomerism. It results from different arrangements of out-of-plane groups 
with respect to a plane. Ligands with central and axial chirality have been explored 
extensively. In contrast, planar chiral ligands have received much less attention 
(Figure 1.3).5 More recently, due to their unique structures and potential to solve 
difficult problems in enantioselective catalysis, planar chiral ligands have started 
to draw interest from the researchers. Most of the planar chiral ligands are based 
on ferrocene derivatives. 
5 
 
 
Figure 1.3:  Example ligands with different types of chirality 
1.3 Chiral ferrocenyl ligands 
1.3.1 Known ligands and their characteristics 
Since their discovery in 1951,6 ferrocene derivatives have been showing 
more and more utility in organometallic chemistry, materials science, and catalysis. 
Chiral ferrocenyl structures are the most widely used type of planar chiral ligands 
in asymmetric catalysis. Many chiral ferrocenyl ligands are known today. 
Compared to other types of chiral ligands, chiral ferrocenyl ligands mainly have 
the following characteristics:7-8 
(1) Rigid conformation: To provide appropriate chiral environment for 
stereo control, the ligand should not be too flexible. The ferrocene unit is rigid, 
therefore, it is a good candidate for ligand framework. 
(2) Planar Chirality: Planar chiral ligands can provide chiral environments 
that cannot be achieved by central and axial chiral ligands. Moreover, planar 
chirality can be combined with central and axial chiralities to solve more 
challenging problems in asymmetric synthesis. 
6 
 
(3) Electronic effects: The electron rich Cp ring gives the ferrocenyl ligand 
e-donor ability. This is particularly important in some cases. For example, by 
coordinating the ferrocenyl ligand to a metal center, the reactivity can be tuned by 
adjusting the electron donating ability of the ferrocene backbone.  
 (4) Versatility and easy modulation: Through structural modulation, a large 
number of ferrocenyl ligands with different electronic and steric properties can be 
easily produced.  
(5) Stability: Ferrocenyl ligands are usually thermally and configurationally 
stable in the solid form and in solution. They are not sensitive to moisture. 
Due to the above characteristics, ferrocene-based ligands have been 
successfully applied in many metal-catalyzed reactions. The most widely used 
ferrocenyl ligands are multi-dentate chiral ferrocenyl phosphine ligands. Due to 
their easy accessibility and high asymmetric efficiency (as shown in Figure 1.4), 
1,2-disubstituted ferrocene derivatives are especially useful. These multidentate 
ligands usually coordinate to the metal center using atoms such as phosphorus and 
nitrogen (P,P and P,N ligands). In some cases of oxygen and sulfur (P,O and P,S 
ligands) can also be used.  
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Figure 1.4: Examples of useful ferrocenyl ligands 
1.3.2 Synthetic routes to chiral ferrocenyl ligands 
1,1′-Disubstituted ferrocene ligands are less common than 1,2-disubstituted 
ones due to side reactions in their synthesis. These include 1,2-substitution and 
symmetrical substitution on both rings.9 The main synthetic methods are 
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summarized in scheme 1.1. Cullen’s method used the ring opening reaction of 1-
phenyl-1-phospha-[1]-ferrocenophane 1. The compound was treated with PhLi, 
the anion intermediate was reacted with an electrophile. Many unsymmetrical 1,1′-
disubstituted ferrocene derivatives were synthesized using this method.10 The 
other methods include selective transmetallation of 2a11 and selective lithiation of 
2b.12-15  
 
Scheme 1.1:  Synthetic routes to 1,1′-disubstituted ferrocene ligands 
For 1,2-disubstituted ferrocene ligands, Ugi was the first to report the 
diastereoselelective ortho-lithiation of (R)-N,N-dimethyl-1-ferrocenylethylamine 
(Ugi’s amine).16 By reacting the resulting intermediate with electrophiles, some 
very useful ligands such as the Josiphos and Walphos ligands were synthesized. 
For lithiation of Ugi’s amine, Two equivalents of n-BuLi together with TMEDA 
can lithiate both Cp rings to give a dilithiated intermediate. The ligand ppfa (N, N-
dimethyl-1-[2-(diphenylphosphino)ferrocenyl]ethylamine) was the first chiral 
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ferrocenyl phosphine ligand synthesized by Ugi’s method.17 Up to now, the Ugi’s 
amine method is still one of the most widely used strategies in synthesizing 
enantiopure 1,2-disubstituted ferrocenyl ligands (Scheme 1.2).  
 
Scheme 1.2: Examples of 1,2-disubstituted ferrocenyl ligands using Ugi’s amine 
In addition to multi-substituted ferrocenyl ligands, some interesting 
heterocyclic ligands were also synthesized (Figure 1.4). These ligands are useful 
in some reactions. For example, Fu developed an efficient method to prepare a 
series of heterocyclic ferrocene type ligands. His group treated FeCl2 with Cp*Li, 
and the intermediate was reacted with the lithium salt of the second planar ring 
(Scheme 1.3).18-19 This method broadened the structural scope of ferrocenyl 
ligands and made possible tuning enantioselectivity by inserting functional groups 
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on the cyclopentadienyl (Cp) ring with different bulkiness such as methyl and 
phenyl groups. This type of ligand was found to be highly enantioselective 
towards a variety of processes, such as isomerization of allylic alcohols, O-H 
insertions, and cyclopropanation.18,20-27 However, the method has a drawback. 
There is no selectivity in the ferrocene-building step, and racemic structures are 
obtained. Most of the ligands made using this method need HPLC resolution on a 
chiral column, which increases the cost and limits their applications on a large 
scale. 
 
Scheme 1.3: Examples of the synthesis of heterocyclic ferrocene-type ligands 
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1.3.3 Applications of chiral ferrocenyl ligands in catalysis 
Due to their excellent chemical and stereochemical features, planar chiral 
ferrocenyl ligands have found wide applications in enantioselective catalysis. 
Scheme 1.4 listed some examples of the applications, which include asymmetric 
hydrogenation,28 asymmetric allylic alkylation,29 and asymmetric 
cyclopropanation.18   
 
Scheme 1.4: Applications of selected chiral ferrocenyl ligands 
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1.4 Salen and salen-type ligands 
Salen ligands are a class of ligands that have N2O2 as electron donors. They 
can form tetradentate metal-salen complexes. The name salen was the 
abbreviation of salicylaldehyde and ethylenediamine, which are substrates used 
for the synthesis of the simplest salen ligand. Although the metal-salen motif has 
been studied for over 60 years, the catalytic applications of chiral salen 
derivatives began in the 1990s. After being extensively explored in the last two 
decades, the salen framework has now been established as one of the most 
“privileged” chiral catalysts: catalysts which are enantioselective over a wide 
range of different reactions.30 Figure 1.5 listed some examples of “privileged” 
catalytic groups. 
 
Figure 1.5: Examples of “privileged” chiral ligands and catalysts 
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The major reason that salen ligands have gained such success in 
asymmetric catalysis is due to the following features: 
(1) Salen ligands are easy to synthesize. Preparation of salen ligand is 
straightforward. They were usually obtained by the condensation of two 
equivalents of a salicylaldehyde with one equivalent of a diamine. Quantitative 
yield can usually be obtained (Scheme 1.5). 
 
Scheme 1.5: Salen ligand and its synthesis 
 (2) The C-2 symmetry of salen ligands: The concept of C-2 symmetry in 
chiral ligand was first introduced by Kagan in 1971.31 The advantage of a C-2 
ligand is that it reduces the number of possible catalyst-substrate arrangements in 
the transition state by factor of two. Among the “privileged” ligands,30 many of 
them including salen complexes possess C-2 symmetry (Figure 1.5).32   
(3) The ability of salen ligands to chelate with a wide range of metal ions: 
For most of the transition metals, the corresponding metal-salen complexes have 
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been reported. Scheme 1.6 lists five different synthetic routes for the preparation 
of metal-salen complexes.33 
 
Scheme 1.6: Preparation of metal-salen complexes 
(4) Structural diversity of salen ligands: Once the appropriate metal is 
identified for a required activity, the structure of the salen ligands can be easily 
modified by modifications of the electron donors, using different chiral diamines 
as the backbone, and modulations on the aldehyde component in some cases, 
which allows systematic tuning of stereo and electronic effects to obtain increased 
stereoselectivity. 
Salen ligands were first reported in early 1990s for Sharpless 
enantioselective epoxidation of simple alkenes lacking allylic hydroxyl groups. 34-
42 Later, they found numerous applications in other reactions. Scheme 1.7 lists 
some well-developed reactions that use salen ligands. They include asymmetric 
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epoxidation,43 asymmetric Strecker reaction44 and asymmetric Diels-Alder 
reaction.45 
    
Scheme 1.7: Selected reactions that use salen ligands 
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1.5 Objectives 
By combining the ideas of ferrocenyl structure and chiral salen ligands 
described above, we designed a new type of chiral ferrosalen ligand. It is based on 
the salen framework. An enantiopure form of ferrocenyl structure was used to 
build the ligands. It is worthy to mention that the stereochemistry effect can be 
enhanced by using a chiral backbone on the salen structure. Because it is 
convenient to change the backbone, enantioselectivity can be easily optimized. 
As shown in Figure 1.6, using the ferrocenyl prototype (R)-4 or (S)-4, 
different C-2 symmetric ferrosalen ligands can be easily prepared by their reaction 
with different achiral and chiral diamines. The synthesis of (R)-4 and (S)-4 were 
achieved by a synthetic route using ferrocene as the starting material, and the 
stereoselective synthesis was completed by a known chiral auxiliary approach, 
followed by a three-step aromatization. This synthetic route will be described in 
Chapter 2 of this dissertation. These results were published in the following article: 
Zhang, Xiang; Luck, Rudy; Fang, Shiyue. Stereoselective Synthesis of a 
Chiral Ferrosalen Ligand Using a Novel Aromatization Strategy. Journal of 
Organometallic Chemistry, 2010, in press.  (doi:10.1016/j.jorganchem.2010.10.064) 
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Figure 1.6: Examples of ferrosalen ligands which can be obtained from (R)-4 
Using the strategy described in Chapter 2, eight ligands based on the 
ferrocene motif with different backbones were synthesized and fully characterized. 
Besides ferrocene-based chiral salen ligands, more sterically hindered chiral salen 
ligands with methyl- and phenyl-substituted Cp rings were also designed. The 
corresponding structure motifs (R)-5 and (S)-6 for ligand synthesis are shown in 
Figure 1.7. These ligands were synthesized with pentamethyl and pentaphenyl 
substituted ferrocene as the starting materials, followed by the similar synthetic 
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route as described in Chapter 2. The increased steric hindrance of these ligands is 
expected to increase enantioselectivity of asymmetric reactions. This research will 
be described in Chapter 3 of this dissertation, and results were submitted as the 
following article: 
Zhang, Xiang; Luck, Rudy; Fang, Shiyue. Ferrosalen and Ferrosalen-type Ligands: 
Structural Modulation and Applications in Asymmetric Catalysis. 
Organometallics, 2011, accepted for publication. 
  
Figure 1.7: Building blocks for the synthesis of methyl- and phenyl- substituted 
ferrocenyl salen ligands 
In Chapter 4 of this dissertation, we will examine the catalytic activities of 
the chiral ferrosalen ligands in three reactions: enantioselective carbonyl-ene 
reaction, enantioselective Strecker-type reaction and enantioselective 
silylcyanation.  
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Chapter 2 
Stereoselective Synthesis of a Chiral Ferrosalen Ligand 
Using an Aromatization Strategy 
 
 
 
Xiang Zhang, Rudy L. Luck, Shiyue Fang 
Journal of Organometallic Chemistry, 2010, in press. 
(doi:10.1016/j.jorganchem.2010.10.064) 
 
 
 
 
 
 
 
 
Reproduced with permission from Elsevier Science. Copyright © 2010 Elsevier B. V., 
see Appendix D.1. 
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Stereoselective Synthesis of a Chiral Ferrosalen Ligand Using 
an Aromatization Strategy 
 
Xiang Zhang, Rudy L. Luck, Shiyue Fang* 
Department of Chemistry, Michigan Technological University, 1400 Townsend 
Drive, Houghton, Michigan 49931 USA 
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Abstract 
A new chiral salen ligand based on two ferrocenyl groups is designed. Unlike 
known salen ligands, of which chirality originates from central and axial chiral 
centers, the chirality of this ligand comes from the planar chiral ferrocenyl groups. 
The ligand is synthesized stereoselectively using a novel aromatization strategy 
starting from a ferrocene derivative, which was readily prepared using a known 
chiral auxiliary approach.  
 
Keywords: Ferrosalen, Planar chiral, Salen, Ferrocene, Ligand 
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Introduction 
Most chiral ligands have narrow reaction scopes and can only be used to 
control the stereoselectivity of a specific reaction. Salen (Figure 2.1) and salen-
type ligands are among a few exceptions including BINAP and bisoxazolines that 
have wide applications.46 For example, salen ligands have been used for 
enantioselective alkene epoxidation, aziridination and cyclopropanation; Diels-
Alder reactions; and kinetic resolution of racemic epoxides.46 In addition to 
applications in enantioselective catalysis, salen and salen-type ligands are also 
useful building blocks in supramolecular chemistry. For example, Zn(II)-salen 
complexes can self-assemble into useful supramolecular architectures.47 Mn(II)-
salen complexes are being used for the construction of superparamagnetic single 
molecule magnets.48-51 Due to the wide applications of salen and salen-type 
compounds, a large number of salen analogs have been synthesized.46,52-56 
Chirality of most salen ligands is attained by rendering chiral the two central 
carbon centers at the 8 and 8′ positions. To solve additional problems, central and 
axial chiral centers were introduced at the 3 and 3′ positions. These new 
generation salen ligands have been found to give higher ees in some 
reactions.39,41,57-58 In addition, chiral salen ligands based on ferrocene have also 
been reported recently.59-62 
 
22 
 
 
Figure 2.1: The salen ligand 
In 2007, our research group initiated a project, which was aimed at 
developing a new class of chiral ferrocenyl ligands based on the structural motifs 1 
and 2 (Figure 2.2).63-66 In order to assess the stability of ligands containing 2, we 
synthesized several model racemic compounds and resolved some of them using 
chiral HPLC. These compounds were used successfully as ligands in several 
reactions, which suggests that they are chemically and configurationally stable. 63-
66 In this article, we report the construction of a salen ligand (+)-3 (Figure 2.2) 
using 2 as the building block. 
 
Figure 2.2: Structural motifs of a new class of chiral ligands (1, 2) and a 
ferrosalen ligand [(+)-3] 
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Results and discussion 
 Having demonstrated the stability of ligands containing motif 2, a 
stereoselective method for the synthesis of building blocks of such ligands, which 
does not rely on chiral HPLC resolution, is highly desirable. In 2001, Kuehne’s 
group developed a method for the preparation of enantiopure ferrocenyl ketone 4 
(Scheme 2.1).67 They reacted (±)-4 with the anion of (+)-5 to give 
diastereoisomers 6a and 6b. These isomers were readily separated with flash 
column chromatography. Heating 6a and 6b in toluene gave enantiopure (+)-4 and 
(-)-4 in quantitative yield. Because (±)-4 and (+)-5 can be readily prepared on 
gram scales, and (+)-4 is easy to functionalize, we decided to access enantiopure 
ligands containing 2 through aromatization of (+)-4 and its derivatives. 
 
Scheme 2.1: Kuehne’s method for the resolution of ferrocenyl ketone (±)-4 
In order to prepare ferrosalen ligand (+)-3, the building block (+)-9 is 
required (Scheme 2.2). Enantiopure (+)-4 was easily formylated to give (+)-7. 
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Installation of a double bond at the position α, β to the carbonyls of (+)-7 would 
give (+)-8, which would tautomerize to (+)-9 under slightly basic or acidic 
conditions. However, we found that this double bond installation was difficult to 
achieve. A simple method would be heating (+)-7 with benzeneseleninic acid 
anhydride in toluene.68 Under these conditions, we were able to synthesize a 
compound resulting from nucleophilic substitution of the anhydride with the enol 
of (+)-7. Unfortunately, heating the adduct gave an intractable mixture instead of 
(+)-8 or (+)-9. Attempted induction of β-elimination by O-alkylation of the 
selenoxide with allyl bromide followed by base treatment also failed. In this case, 
we could isolate the alkylation product, but when this was treated with bases such 
as NaH or t-BuLi, (+)-7 was obtained. Other experimental conditions involving 
selenium chemistry69-70 and the β-hydride-elimination process of palladium 
chemistry71 also failed. Further, the use of stoichiometric amounts of Pd(OAc)2 did 
not produce (+)-8 either. Because all the methods using selenium and palladium 
chemistry involve an intramolecular concerted or close to concerted elimination 
step, it is possible that the steric hindrance and conformational rigidity of the 
intermediates for the elimination prevented the formation of the cyclic transition 
state required for the reaction. Based on this hypothesis, we next employed a two-
step elimination process. To this end, (+)-7 was converted to the methyl enol ether 
(+)-10 in 89% yield by stirring with dimethyl sulfate and cesium carbonate in 
warm DMF (Scheme 2.3). 
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Scheme 2.2: Early attempts to synthesize (+)-9 from enantiopure (+)-4 
 
Scheme 2.3: O-Methylation of (+)-7 
Next, compound 10 was subjected to halogenation in methanol using 
different N-halosuccinimides. In entries 1, 2 and 5, (±)-10 was used as the 
substrate to test the reaction which was obtained from (±)-4 following the 
procedure similar to that of (+)-10. With NIS as the reagent, at 0 ˚C the halo 
dimethyl acetal product (±)-11a was obtained in 52% yield (entry 1, Table 2.1). 
Performing the reaction at room temperature increased the yield to 68% (entry 2). 
When the halogenation agent was changed to NBS, at both 0 ˚C and room 
temperature, product (+)-11b was isolated in 71% yield (entries 3 and 4). 
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Halogenation with NCS resulted in a 57% yield of (+)-11c under similar 
conditions (entry 5). 
Table 2.1 
Halogenation of methyl enol ether 10 
 
 
 
 
 
 
 
 
 
These α-halo ketone compounds were then subjected to various base 
initiated β-elimination conditions. When (+)-11b was treated with potassium 
carbonate in DMF at 80 ˚C, the enol ether (+)-10 was isolated (entry 1, Table 2.2). 
Under similar conditions at room temperature, the stronger base cesium carbonate 
resulted in small amounts of (+)-12 (entry 2); at 80 ˚C, the product was (+)-10 
(entry 3). We then employed the strong and less hindered base sodium methoxide 
for the reaction. In DMF at room temperature, (+)-11b was consumed in 1 hour as 
evident in a TLC test, and the desired product (+)-9 was isolated in 68% yield 
along with small quantities of (+)-12 (entry 4). To see if a stronger and less 
Entrya NXS Temperature Product Yield (%)b 
1  NIS 0 ˚C (±)-11a 52 
2  NIS rt (±)-11a 68 
3 NBS 0 ˚C (+)-11b 71 
4 NBS rt (+)-11b 71 
5  NCS 0 ˚C (±)-11c 57c 
a Conditions: 10, NXS, MeOH.  
b Isolated yields.  
c 1,4-Diazabicyclo[2,2,2]octane was added. 
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hindered base could give a higher yield, (+)-11b was stirred with sodium hydride 
in DMF at room temperature; however, the yield of (+)-9 was lowered to 54%, and 
(+)-10 and (+)-12 were also produced (entry 5). Treating (±)-11c with either 
sodium methoxide or sodium hydride at room temperature did not yield (±)-9 
(entries 6 and 8). Upon heating to 70 ˚C, (±)-12 was isolated in 40% yield in the 
case of sodium methoxide (entry 7); in the case of sodium hydride, (±)-9 was 
formed in 35% yield along with 20% of (±)-12 (entry 9). Based on these results 
(entry 6-9), (±)-11c is not a useful substrate to prepare (±)-9. Treating the iodo 
substrate (±)-11a with sodium hydride at room temperature did afford (±)-9 in 38% 
yield but most of the substrates were converted to (±)-10 (entry 10). 
The structure of (+)-9 was readily established with NMR and high 
resolution MS. The structure of (+)-12 was first established by X-ray 
crystallography (Figure 2.3), and then confirmed with NMR and MS. Suitable 
crystals of the racemic (±)-12 which was obtained from (±)-4 following the same 
procedure were grown because the pure enantiomer did not crystallize. Even 
though compounds (+)-9 and (+)-12 are tautomers, we could not accomplish their 
interconversion under either basic or acid conditions. For example, when treated 
with NaH in THF at reflux temperature, (+)-12 was unreactive. Other basic 
conditions such as Et3N/THF/50 ˚C, 10% K2CO3/THF/50 ˚C, and NaOMe/DMF/rt 
gave similar results. With 10% KOH/THF/50 ˚C, (+)-12 partially decomposed 
after 12 hours, and (+)-9 was not formed. Stirring solutions of (+)-12 in THF with 
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acetic acid at room temperature returned the starting material; when heated to 50 
˚C, the compound started to decompose after 5 min. Without any added base or 
acid, heating (+)-12 in toluene in a sealed tube to 195 ˚C to induce a thermo 1,5-
hydrogen shift gave an intractable mixture after 12 hours. At lower temperatures 
(170 ˚C), (+)-12 was stable. Under similar conditions described above, attempts to 
convert (+)-9 to (+)-12 also failed. 
Table 2.2 
 Synthesis of 9 via β-elimination of 11 
Entrya Substrate Base T Time 
Yieldb 
(+)-10 (+)-12 (+)-9 
1 (+)-11b (Br) K2CO3 80 ˚C 12 h 40% 0% 0% 
2 (+)-11b (Br) Cs2CO3 rt 4 h 0% 8% 0% 
3 (+)-11b (Br) Cs2CO3 80 ˚C 12 h 46% 0% 0% 
4 (+)-11b (Br) NaOMe rt 1 h 0% 9% 68% 
5 (+)-11b (Br) NaH rt 12 h 10% 10% 54% 
6 (±)-11c (Cl) NaOMe rt 12 h 0% 0% 0% 
7 (±)-11c (Cl) NaOMe 70 ˚C 1 h 0% 40% 0% 
8 (±)-11c (Cl) NaH rt 12 h 0% 0% 0% 
9 (±)-11c (Cl) NaH 70 ˚C 12 h 0% 20% 35% 
10 (±)-11a (I) NaH rt 12 h 54% 0% 38% 
a Conditions: 11, base, DMF.  
b Isolated yields. 
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Figure 2.3: An ORTEP372 representation of complex (±)-12. The FeCp bond 
distances range from 2.025(5) to 2.039(5) Å, average of 2.031(5) Å and 2.019(5) – 
2.036(5) Å, average of 2.026(6) Å respectively for the Fe1 and Fe2 labeled complexes.  
The corresponding Fe distances to the substituted indenyl C-atoms range from 2.034(4) 
to 2.063(4) Å, average of 2.05(1) Å and 2.026(5) to 2.083(5) Å, average of 2.05(2) Å for 
the Fe1 and Fe2 labeled complexes respectively.  Fe1-C6 and Fe2-C21 were the largest 
distances suggesting a skewed arrangement of the indenyl ligand.  The corresponding 
C=O ketone and alcohol C-O distances were 1.258(4), 1.352(5) Å and 1.250(5), 1.343(6) 
Å for the Fe1 and Fe2 labeled complexes respectively. 
 
Now that a stereoselective method for the preparation of building block (+)-
9 was developed (Table 2.2, entry 4), the synthesis of ferrosalen ligands and their 
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metal complexes can be achieved using reported procedures. For example, stirring 
(+)-9 with 1,2-ethanediamine in anhydrous methanol at room temperature for 5 
hours gave (+)-3 in 71% yield.73 Complexation of (+)-3 with Cu(II) to give (+)-13 
was achieved by stirring with cupric acetate in ethanol and water at room 
temperature for 2 hours (75%) (Scheme 2.4).74 
 
 
Scheme 2.4: Synthesis of ferrosalen ligand (+)-3 and its Cu(II) complex (+)-13 
Many reported methods for the synthesis of non-racemic planar chiral 
ferrocenyl ligands consume stoichiometric amounts of chiral starting materials.75-76 
For example, the widely used 2-ferrocenyloxazolines and 1,1′-
bis(oxazolinyl)ferrocenes were synthesized from enantiopure amino acids.75 
Additionally some highly useful planar chiral ligands and catalysts were made 
non-stereoselectively and enantiomers were resolved using chiral HPLC.77 
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Although Fu’s group recently made significant progress on the resolution of two 
such catalysts,19 the yields of enantiopure products were still low, and the method 
is not applicable to compounds that are unstable in acid or unreactive with acid, a 
direct measure of the difficulties in the field. Recently, Kündig’s group developed 
a catalytic enantioselective method to access planar chiral building blocks through 
the desymmetrization of meso precursors.78-79 However, adapting this technology 
to synthesize (+)-9 is not straightforward. 
The method described in this paper does not consume any chiral starting 
materials and the synthesis is stereoselective. The chiral auxiliary (+)-5 used for 
resolution of (±)-4 is commercially available, and can be prepared on multigram 
scales.80-81 In addition, when used for resolution of (±)-4, (+)-5 could be recovered 
quantitatively and be reused repeatedly. For the installation of the double bond in 
(+)-7 to synthesize (+)-9, we used a three-step method. Compared with methods 
involving selenium and palladium chemistry, this route has the advantage of using 
less toxic and inexpensive reagents. 
Conclusions 
 We have designed and synthesized a new ferrosalen ligand. This ligand has 
unique structural features that are expected to be beneficial for improving 
enantioselectivities of some catalytic reactions. The key benzoferrocenyl building 
block (+)-9 for the preparation of the ligand was synthesized stereoselectively. The 
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aromatization of enantiopure (+)-7 to benzoferrocene derivative (+)-9 represents 
an unprecedented strategy for the synthesis of chiral ferrocenyl ligands. This 
strategy may be applicable for the preparation of other planar chiral ferrocenyl 
ligands and catalysts that have previously found wide utility.77 Research on 
structural modulation of the ligand and the use of such ligands to solve problems 
in asymmetric catalysis is underway. 
Experimental section 
4.1. (+)-(R)-η5-[5-(E)-Hydroxymethylene-4-oxo-4,5,6,7-tetrahydro-3H-indenyl]-
η5-cyclopentadienyliron [(+)-7]. A two-neck  round-bottom flask charged with 
enantiopure (+)-4 (1.63 g, 5.78 mmol; R-enantiomer is used as an example) and 
THF (20 mL) was cooled on an ice bath. NaH (0.694 g, 17.34 mmol) was added 
under positive N2 pressure. After heating the mixture to reflux for 0.5 h, HCOOEt 
(1.28 g, 1.40 mL, 17.34 mmol) was added via a syringe. Reflux was continued for 
an additional 2 h, and the reaction mixture was allowed to cool to rt and then to 0 
˚C. Et2O (30 mL) was added, and the mixture was transferred to a separation 
funnel. The organic phase was washed with 5% HCl solution (50 mL). The 
aqueous portion was extracted with ether (25 mL × 3). The organic phase and 
extracts were combined, washed with brine, dried over anhydrous Na2SO4, and 
filtered. Solvents were removed under reduced pressure. Purification by flash 
column chromatography (SiO2, hexanes/Et2O 2 : 1) gave (+)-7 as a red oil (1.68 g, 
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93%): Rf = 0.40 (SiO2, hexanes/Et2O 1 : 1); [α]22D = +21° (c = 0.010, CHCl3); 1H 
NMR (CDCl3) δ 7.35 (s, 1H, CHO), 4.76 (br s, 1H, H-1 or 3), 4.50 (t, J = 2.4 Hz, 
1H, H-2), 4.42 (br s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 2.83 (td, J = 14.0, 5.6 Hz, 1H, 
H-5), 2.88-2.25 (m, 4H, H-6 and 7); 13C NMR (CDCl3) δ 196.6 (C-4), 163.7 
(CHO), 109.0 (C-5), 92.4 (C-3a or C-7a), 75.3 (C-3a or C-7a), 70.9 (C-1 or 2 or 3), 
70.3 (C-1 or 2 or 3), 70.1 (Cp), 64.1 (C-1 or 2 or 3), 25.2 (C-6 or 7), 22.7 (C-6 or 
7); HRMS (ESI) m/z calcd for C15H14FeO2 [M]+ 283.0421, found 283.0413.  
4.2. (+)-(R)-η5-[5-(E)-Methoxymethylene-4-oxo-4,5,6,7-tetrahydro-3H-
indenyl]-η5-cyclopentadienyliron [(+)-10]. To a two-neck  round-bottom flask 
charged with (+)-7 (6.48 g, 22.98 mmol; R-enantiomer is used as an example) and 
DMF (40 mL) was added Cs2CO3 (15.0 g, 45.96 mmol) under positive N2 pressure. 
The mixture was heated to 50 ˚C for 1 h on an oil bath. Me2SO4 (4.38 mL, 45.96 
mmol) was then added via a syringe. Heating was continued for an additional 20 
min, and the reaction mixture was cooled to rt. N2-bubbled 10% K2CO3 (100 mL) 
was added slowly to the flask via a syringe. The mixture was then transferred to a 
separation funnel, and was extracted with Et2O (40 mL × 4). The ether extracts 
were combined, dried over anhydrous Na2SO4, and filtered. Solvents were 
removed under reduced pressure. The mixture contained product (+)-10 (4.39 g) 
and the starting material (+)-7 (1.78 g), which were separated readily with flash 
column chromatography (SiO2, hexane/Et2O 1 : 2). Product (+)-10 was obtained as 
a red oil  in 89% yield (based on recovered starting material): Rf = 0.35 (SiO2, 
34 
 
hexane/Et2O 1 : 2); [α]22D = +30° (c = 0.013, CHCl3); 1H NMR (C6D6) δ 7.42 (d, J 
= 2.4 Hz, 1H, H-COMe), 4.95 (m, 1H, H-1 or 3), 4.04 (t, J = 2.4 Hz, 1H, H-2), 
3.99 (m, 1H, H-1 or 3), 3.88 (s, 5H, Cp), 3.09-3.02 (m, 1H, H on C-6 or 7), 3.04 (s, 
3H, H3C-O), 2.70-2.60 (m, 1H, H on C-6 or 7), 2.21-2.15 (m, 2H, H on C-6 or 7); 
13C NMR (C6D6) δ 191.7 (C-4), 155.1 (C-OMe), 114.9 (C-5), 92.5 (C-3a or C-7a), 
78.0 (C-3a or C-7a), 70.1 (C-1 or 2 or 3), 70.0 (Cp), 69.7 (C-1 or 2 or 3), 65.5 (C-1 
or 2 or 3), 60.4 (OCH3), 23.1 (C-6 or 7), 22.4 (C-6 or 7); HRMS (ESI) m/z calcd 
for C16H17FeO2 [M + H]+ 297.0578, found 297.0569. The E geometry of the 
double bond of the methyl enol ether was established by NOE. NOE was observed 
between hydrogens on the methyl group and those on C-6.  
4.3. (±)-η5-[5-endo-Dimethoxymethyl-5-exo-iodo-4-oxo-4,5,6,7-tetrahydro-3H-
indenyl]-η5-cyclopentadienyliron [(±)-11a]. A two-neck  round-bottom flask was 
charged with racemic (±)-10 (0.80 g, 2.71 mmol) and MeOH (20 mL), and 
wrapped with aluminum foil. To the flask was added N-iodosuccinimide (0.82 g, 
3.62 mmol) in 5 portions in a 20 min period under positive N2 pressure. The 
reaction was complete in 10 min after addition as indicated by TLC. The mixture 
was partitioned between water (40 mL) and CH2Cl2 (40 mL). The aqueous phase 
was further extracted with CH2Cl2 (200 mL × 3). The combined organic phases 
were washed with brine, dried over anhydrous Na2SO4, and filtered. Solvents were 
removed under reduced pressure. Purification by flash column chromatography 
(SiO2, hexane/Et2O 8 : 1 then 3 : 1) gave racemic (±)-11a as a red solid (0.84 g, 
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68%): Rf = 0.70 (SiO2, hexane/Et2O 1 : 1); mp 138-140 ˚C; 1H NMR (CDCl3) δ 
5.25 (s, 1H, H-CO2), 4.82 (br s, 1H, H-1 or 3), 4.49 (t, J = 2.4 Hz, 1H, H-2), 4.44 
(br s, 1H, H-1 or 3), 4.18 (s, 5H, Cp), 3.65 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 
2.56-2.50 (m, 1H, H on C-6 or 7); 2.34-2.24 (m, 3H, H on C-6 or 7); 13C NMR 
(CDCl3) δ 197.3 (C-4), 108.9 (C-OMe), 90.3 (C-3a or C-7a), 72.6 (C-3a or C-7a), 
71.4 (C-1 or 2 or 3), 70.3 (C-1 or 2 or 3), 70.2 (Cp), 66.4 (C-1 or 2 or 3), 59.6 
(OCH3), 59.1 (OCH3), 55.8 (C-5), 31.4 (C-6 or 7), 23.0 (C-6 or 7); HRMS (ESI) 
m/z calcd for C17H20FeIO3 [M + H]+ 454.9807, found 454.9797. The reaction was 
also performed at 0 ˚C for 1 h, (±)-11a was obtained in 52% yield.  
4.4. (+)-(R)-η5-[(5S)-5-Bromo-5-dimethoxymethyl-4-oxo-4,5,6,7-tetrahydro-3H-
indenyl]-η5-cyclopentadienyliron [(+)-11b]. Following the same procedure used 
for the preparation of (+)-11a, compound (+)-10 (6.09 g, 20.6 mmol; R-
enantiomer is used as an example) was reacted with N-bromosuccinimide (7.32 g, 
41.2 mmol) in MeOH (50 mL) at rt. The product was purified by flash column 
chromatography (SiO2, hexane/Et2O 8 : 1 then 4 : 1), and compound (+)-11b was 
obtained as a red solid (5.93 g, 71%): Rf = 0.65 (SiO2, hexane/Et2O 1 : 1); mp 120-
122 ˚C (dec); [α]21D = + 194° (c=0.010, CHCl3); 1H NMR (CDCl3) δ 5.14 (s, 1H, 
H-CO2), 4.84 (d, J = 1.6 Hz, 1H, H-1 or 3), 4.52 (t, J = 2.4 Hz, 1H, H-2), 4.48 (br 
s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 3.67 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 2.77-
2.71 (m, 1H, H on C-6 or 7), 2.57-2.53 (m, 2H, H on C-6 or 7), 2.41 (dt, J = 14.4, 
2.8 Hz, 1H, H on C-6 or 7); 13C NMR (CDCl3) δ 196.1 (C-4), 107.6 (C-OMe), 
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90.8 (C-3a or C-7a), 72.7 (C-3a or C-7a), 71.7 (C-1 or 2 or 3), 70.5 (C-1 or 2 or 3), 
70.3 (Cp), 66.9 (C-5), 66.3 (C-1 or 2 or 3), 59.4 (OCH3), 59.2 (OCH3), 29.8 (C-6 
or 7), 20.6 (C-6 or 7); HRMS (ESI) m/z calcd for C17H20BrFeO3 [M + H]+ 
406.9945, found 406.9942. The reaction was also performed at 0 ˚C, the same 
yield was obtained.  
4.5. (±)-η5-[5-exo-Chloro-5-endo-dimethoxymethyl-4-oxo-4,5,6,7-tetrahydro-
3H-indenyl]-η5-cyclopentadienyliron [(±)-11c]. Following the same procedure 
used for the preparation of (±)-11a, (±)-10 (0.60 g, 2.02 mmol) was reacted with 
N-chlorosuccinimide (0.81 g, 6.06 mmol) in the presence of 1,4-
diazabicyclo[2,2,2]-octane (0.23 g, 2.02 mmol) in MeOH (15 mL) at 0 ˚C. The 
product was purified by flash column chromatography (SiO2, hexane/Et2O 4 : 1), 
and (±)-11c (0.35 g) was obtained as a red solid in 57% yield (based on 90 mg 
recovered starting material): Rf = 0.65 (SiO2, hexane/Et2O 1 : 2); mp 118-122 ˚C; 
1H NMR (CDCl3) δ 5.03 (s, 1H, H-CO2), 4.83 (br s, 1H, H-1 or 3), 4.53 (t, J = 2.4 
Hz, 1H, H-2), 4.49 (br s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 3.67 (s, 3H, OCH3), 3.64 
(s, 3H, OCH3), 2.86-2.78 (m, 1H, H on C-6 or 7); 2.68-2.58 (m, 1H, H on C-6 or 
7); 2.56-2.49 (m, 1H, H on C-6 or 7), 2.44-2.36 (m, 1H, H on C-6 or 7); 13C NMR 
(CDCl3) δ 196.3 (C-4), 107.4 (C-OMe), 91.1 (C-3a or C-7a), 72.6 (C-3a or C-7a), 
71.7 (C-1 or 2 or 3), 70.6 (C-1 or 2 or 3), 70.3 (Cp), 70.2 (C-5), 66.1 (C-1 or 2 or 
3), 59.5 (OCH3), 58.9 (OCH3), 29.1 8 (C-6 or 7), 19.3 8 (C-6 or 7); HRMS (ESI) 
m/z calcd for C17H20ClFeO3 [M + H]+ 363.0450, found 363.0464.  
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4.6. (+)-(R)-η5-[5-Formyl-4-hydroxy-3H-indenyl]-η5-cyclopentadienyliron [(+)-9] 
and (+)-(R)-η5-[5-(Z)-hydroxymethylidene-4-oxo-4,5-dihydro-3H-indenyl]-η5-
cyclopentadienyliron [(+)-12]. A two-neck  round-bottom flask was charged with 
(+)-11b (821 mg, 0.975 mmol; R-enantiomer is used as an example) and DMF (8 
mL). NaOMe (574 mg, 4.87 mmol) was added at rt under positive N2 pressure. 
TLC indicated that the reaction was complete in 1 h. To the reaction mixture, N2-
bubbled saturated NH4Cl solution (20 mL) was added via a syringe. After stirring 
for an additional 30 min, N2-bubbled Et2O (25 mL) was added via a syringe. The 
mixture was further stirred for 30 min. The contents were then transferred to a 
separatory funnel, and the organic and aqueous layers were separated. The 
aqueous layer was further extracted with Et2O (20 mL × 5). The combined organic 
phases were washed with brine, dried over anhydrous Na2SO4, and filtered. 
Solvents were removed under reduced pressure. TLC indicated that the mixture 
contained two major spots, which corresponds to compounds (+)-9 and (+)-12. 
These two compounds were purified with flash column chromatography (SiO2, 
hexane/Et2O 8 : 1 then 2 : 1). Compound (+)-9 was obtained as a red solid (384 
mg, 68%): Rf = 0.63 (SiO2, hexane/Et2O 1 : 1); mp 39-41 ˚C; [α]24D = +749.3° (c = 
0.010, CH2Cl2); 1H NMR (CDCl3) δ 9.57 (s, 1H, CHO), 6.95 (d, J = 9.2 Hz, 1H, 
H-6 or 7), 6.83 (d, J = 8.8 Hz, 1H, H-6 or 7), 5.21 (br s, 1H, H-1 or 2 or 3), 5.01 
(br s, 1H, H-1 or 2 or 3), 4.42 (br s, 1H, H-1 or 2 or 3), 3.89 (s, 5H, Cp); 13C NMR 
(CDCl3) δ 192.8 (CHO), 175.8 (C-4), 123.2 (C-6 or 7), 117.8 (C-6 or 7), 110.8 (C-
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5), 91.0 (C-3a or C-7a), 75.0 (C-3a or C-7a), 73.1 (C-1 or 2 or 3), 69.6 (Cp), 65.3 
(C-1 or 2 or 3), 62.2 (C-1 or 2 or 3); HRMS (ESI) m/z calcd for C15H12FeO2 [M]+ 
280.0187, found 280.0181. Compound (+)-12 was obtained as a red solid (51 mg, 
9%): Rf = 0.20 (SiO2, hexane/Et2O 1 : 2); mp 151-155 ˚C (dec); [α]24D = +93.3° (c 
= 0.005, Et2O); 1H NMR (CDCl3) δ 10.52 (br s, 1H, OH), 7.37 (d, J = 11.2 Hz, 1H, 
HC-OH), 6.30 (s, 2H, H-6 and 7), 5.08 (br s, 1H, H-1 or 3), 4.68 (br s, 1H, H-1 or 
3), 4.35 (t, J = 2.4 Hz, 1H, H-2), 3.95 (s, 5H, Cp); 13C NMR (CDCl3) δ 192.4 (C-
4), 153.4 (CH-OH), 126.7 (C-6 or 7), 113.2 (C-6 or 7), 108.0 (C-5), 89.2 (C-3a or 
C-7a), 78.1 (C-3a or C-7a), 70.8 (C-1 or 2 or 3), 70.1 (Cp), 66.3 (C-1 or 2 or 3), 
64.4 (C-1 or 2 or 3); HRMS (ESI) m/z calcd for C15H12FeO2 [M]+ 280.0187, found 
280.0197. Attempts to use enantiopure (+)-12 to grow crystals were not successful. 
The crystal of (±)-12 used for X-ray diffraction analysis was obtained by slow 
evaporation of pentane into a solution of (±)-12 in CH2Cl2 under a N2 atmosphere 
at rt. Crystallographic data are listed in Table 2.3. The crystallographic data 
(excluding structure factors; CCDC no. 771464) have been deposited to the 
Cambridge Crystallographic Data Centre. Copies of these data can be obtained, 
free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, 
UK; fax: +044 1223 336033 or via e-mail: deposit@ccdc.cam.uk or via 
www.ccdc.cam.ac.uk/conts/ retrieving.html. The structure can also be found in the 
supporting information.  
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Table 2.3 
Crystal data and structure refinement parameters for complex (±)-12 
 
Empirical formula C30H24Fe2O4 
Formula weight 560.19 
Temperature 291(2) K 
Wavelength 0.71069 Å 
Crystal system, space group orthorhombic, Pcab 
Unit cell dimensions 
a = 12.528(2) Å 
b = 13.067(2) Å 
c = 30.419(5) Å 
Z, Calculated density 8,  1.494 Mg/m3 
Absorption coefficient 1.200 mm-1 
F(000) 2304 
Crystal size 0.35 x 0.25 x 0.15 mm 
Theta range for data collection 1.34 to 22.47 ° 
Limiting indices 0<=h<=13, 0<=k<=14, -1<=l<=32 
Reflections collected / unique 3385 / 3242 [R(int) = 0.0267] 
Completeness to theta = 22.47 100.0 % 
Max. and min. transmission 0.8405 and 0.6788 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3242 / 0 / 325 
Goodness-of-fit on F2 1.060 
Final R indices [I > 2(I)] R1 = 0.0375; wR2 = 0.0768 
R indices (all data) R1 = 0.0836; wR2 = 0.0911 
Largest diff. peak and hole 0.288 and -0.290 e/A3 
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The synthesis of 9 was also carried out under other reaction conditions 
using compounds 11a-c as the starting materials. Results have been summarized in 
Table 2.2.  
4.7. (+)-N,N′-Bis{(R)-[η5-(η5-cyclopentadienylironyl)-4-hydroxy-3H-5-inden-5-
ylmethylidene]}ethylenediamine [(+)-3]. The solution of (+)-9 (200.9 mg, 0.718 
mmol) and 1,2-ethanediamine (21.6 mg, 0.36 mmol; R-enantiomer is used as an 
example) in MeOH (10 mL) was stirred at rt under a N2 atmosphere. After 5 h, the 
solvent was removed under reduced pressure. Purification of the residue by flash 
column chromatography (SiO2, Et2O/MeOH/Et3N 40 : 3 : 2) gave (+)-3 as a red 
foam (150 mg, 71%): Rf = 0.30 (SiO2, Et2O/MeOH/Et3N 40 : 3 : 2); [α]22D = 
+566.7 (c = 0.001, CHCl3); 1H NMR (CDCl3) δ 7.13 (s, 1H, HC=N), 7.10 (s, 1H, 
HC=N), 6.21 (d, J = 9.6 Hz, 2H, H-6 or 7), 6.20 (d, J = 9.2 Hz, 2H, H-6 or 7), 5.04 
(br s, 2H, H-1 or 3), 4.63 (br s, 2H, H-1 or 3), 4.30 (t, J = 2.0 Hz, 2H, H-2), 3.91 (s, 
10H, Cp), 3.48 (s, 4H, CH2-N); 13C NMR (CDCl3) δ 191.1 (C-4), 155.5 (C=N), 
126.1 (C-6 or 7), 113.0 (C-6 or 7), 107.3 (C-5), 89.1 (C-3a or C-7a), 77.9 (C-3a or 
C-7a), 70.7 (C-1 or 2 or 3), 70.0 (Cp), 66.1 (C-1 or 2 or 3), 64.1 (C-1 or 2 or 3), 
50.0 (CH2-N); HRMS (ESI) m/z calcd for C32H28Fe2N2O2 [M]+ 585.0928, found 
585.0936.  
4.8. (+)-N,N′-Bis{(R)-[η5-(η5-cyclopentadienylironyl)-4-oxido-3H-inden-5-
ylmethylidene]}ethylenediaminato copper (II) [(+)-13]. A two-neck  round-bottom 
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flask was charged with (+)-3 (27.6 mg, 0.047 mmol; R,R-enantiomer is used as an 
example) and the solvent mixture EtOH/H2O (9:1, 3.3 mL). Cupric acetate (9.5 mg, 
0.047 mmol) was added under positive N2 pressure. After stirring at rt for 2 h, 
volatile components were removed under reduced pressure. The deep red solid 
was suspended in EtOH (2 mL) and poured onto a pad of Celite. The solid on the 
Celite was further washed with cold EtOH (1 mL × 2). Then, to the Celite was 
added CH2Cl2 (3 mL). The red solid was dissolved and was filtered into a clean 
round-bottom flask. The Celite was further washed with CH2Cl2 (3 mL × 2). The 
combined red solution was evaporated under reduced pressure giving compound 
(+)-13 as a red crystalline solid (22.8 mg, 75%): [α]24D = +2551.0 (c = 0.004, 
CH2Cl2); HRMS (ESI) m/z calcd for C32H26CuFe2N2O2 [M]+ 644.9989, found 
644.9971. This compound is paramagnetic, and was not characterized with NMR. 
The image of its LRMS is shown in Figure S2 in the supporting information.  
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Abstract 
Several ferrosalen and ferrosalen-type ligands, (-)-1 to (-)-10, were 
prepared and fully characterized. The structure of one of these ligands ligated to 
Cu(II) was determined by single-crystal X-ray diffraction analysis. In comparison 
with the parent ligand (-)-1, the two six-membered rings of ligand (-)-2 are not 
aromatized and the synthesis was more facile. Diastereoisomers (+)-3 and (-)-4, 
containing substituents on the ethylene chain, were synthesized. The aromatized 
versions of (+)-3 and (-)-4, namely (+)-5 and (-)-6, were also prepared. Further 
modulation of the ethylene backbone produced ligands (+)-7 and (-)-8. Replacing 
the Cp ligands with Cp* and CpPh5 gave ligands (+)-9 and (-)-10, respectively. All 
these ligands were tested for catalytic asymmetric reactions, including the Co(III)-
catalyzed carbonyl-ene reaction, Al(III)-catalyzed Strecker reaction, and Al(III)-
catalyzed silylcyanation of aldehydes. 
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Introduction 
Salen and salen-type ligands have been widely used in asymmetric catalysis. 
Most of these ligands were rendered chiral by introduction of two central chiral 
centers at the 8- and 8′-positions in their backbone. To solve certain selected 
problems such as enantioselective epoxidation of conjugated cis-olefins and 
unfunctionalized olefins, Katsuki’s group designed and synthesized salen ligands 
that contain central or axial chiral centers at the 3- and 3′-positions.39,41,57-58 
Recently, salen and salen-type ligands that contain the planar chiral ferrocenyl 
moieties were also reported in the literature. For example, Ballistreri and co-
workers used ferrocene-containing diamines for salen-type ligand synthesis. The 
resulting ligands contained one or more ferrocenyl groups in their backbone.59 
Bildstein’s group incorporated one or more ferrocenyl groups into the front part of 
salen-type ligands.60 Erker’s group used hydroxyferrocene as the building block 
for salen-type ligand synthesis. In this case, the bulky FeCp groups are very close 
to the catalytic center, which may be beneficial for stereocontrol.61-62 
 
Figure 3.1: The two structural motifs of a new class of chiral ligands 
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Three years ago, we started to develop a new class of chiral ferrocenyl 
ligands based on two common structural motifs (Figure 3.1). Our preliminary 
results showed that such ligands are chemically and configurationally stable, and 
are compatible with several catalytic reaction conditions.63-66 More recently, we 
have successfully developed a stereoselective method to access this class of 
ligands such as (-)-1 (Figure 3.2). As a result, we no longer need to rely on chiral 
HPLC resolution to obtain them in enantiopure form, and gram-sized quantities 
can be synthesized conveniently.82 In addition, this synthetic route provided an 
opportunity to modulate the steric hindrance at the ethylene backbone and at the 
FeCp groups. In this paper, we wish to report the synthesis and characterization of 
ligands (-)-2 to (-)-10 (Figure 3.2), and their use for the Co(III)-catalyzed 
carbonyl-ene reaction, Al(III)-catalyzed Strecker reaction, and Al(III)-catalyzed 
silylcyanation of aldehydes. 
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Figure 3.2: Ferrosalen and Ferrosalen-type ligands 
 
 
 
Scheme 3.1: Synthesis of ligand (-)-2 and the Cu(II) complex (-)-12 
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Results and Discussion 
The synthesis of ligand (-)-1 (both enantiomers are accessible) has been 
reported previously.82 Ligand (-)-2 is the unaromatized version of (-)-1.  As the 
synthesis of (-)-2 is several steps shorter, it was prepared to evaluate usefulness in 
asymmetric catalysis. This unaromatized ligand may also display useful electronic 
and steric properties in catalysis. As shown in Scheme 3.1, enantiopure (-)-11(both 
enantiomers are accessible; the S enantiomer was used)82 was condensed with 1,2-
ethanediamine in anhydrous methanol at room temperature.37 Ligand (-)-2 was 
obtained in quantitative yield as a red foam. Stirring (-)-2 with cupric acetate in a 
solvent mixture of ethanol and water at room temperature gave the Cu(II) complex 
(-)-12 in 75% yield (Scheme 3.1).74 Compound (-)-12 is paramagnetic and was not 
characterized by NMR, but HRMS contained a peak equal to the calculated 
molecular weight. We were also successful in growing crystals for X-ray 
diffraction analysis (Figure 3.3). In the solid-state structure, like most metallosalen 
complexes in the absence of multidentate ancillary ligands, (-)-12 adopts a trans 
configuration. Although there is no substituent at the 1,2-ethanediamino backbone, 
the five-membered ring containing Cu(II) and two nitrogen atoms are in a half-
chair conformation.  This produces an overall stepped conformation for the 
metallosalen complex.54 
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Figure 3.3: ORTEP-3 structure of (-)-12.72 Displacement ellipsoids are drawn at the 
30% probability level, H atoms are represented by circles of arbritary radii.  Selected 
bond lengths (Å) and angles (deg) for 12: Fe1-C1 2.012(12), Fe1-C2 2.041(14), Fe1-C3 
2.006(14), Fe1-C4 2.024(11), Fe1-C5 2.028(11), Fe1-C6 2.023(11), Fe1-C7 2.009(12), 
Fe1-C8 2.037(11), Fe1-C9 2.067(10), Fe1-C10 2.082(11), Cu1-O1 1.927(7), Cu1-N1 
1.936(8), N1-C15 1.326(14), N1-C16 1.453(13), O1-Cu1-O1′ 91.8(4), O1-Cu1-N1′ 
165.6(3), O1-Cu1-N1 93.9(4), N1′-Cu1-N1 83.7(6) equivalent atoms generated by -x+2,-
x+y+1,-z+1/3 
 
Ligands (+)-3 and (-)-4 are diastereoisomers. In catalytic applications, they 
should display different efficiencies in stereocontrol. Their syntheses were 
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achieved by condensing the commercially available enantiopure (+)-13 with (+)- 
and (-)-11 in anhydrous methanol, respectively (Scheme 3.2). Good isolated yields 
were obtained. Ligands (+)-5 and (-)-6 are also diastereoisomers. They are the 
aromatized version of compounds (+)-3 and (-)-4. Their syntheses were 
accomplished under similar conditions for the synthesis of (+)-3 and (-)-4 using 
(+)-13 and the two enantiomers of compound 14 (Scheme 3.2).82 The 
ethylenediamine backbone of ferrosalen (+)-5 and (-)-6 was changed to 1,2-
cyclohexanediamine (-)-15 to give ligands (+)-7 and (-)-8 (Scheme 3.2) utilizing 
similar synthetic conditions. Ligands (-)-3 to (-)-8 were fully characterized by 1H 
and 13C NMR and HRMS. They are stable deep red crystalline solids, and in 
solution, they are stable under inert atmospheres. Upon exposure to air, the 
solutions turn green, indicating oxidation occurred; this is typical for ferrocenyl 
compounds. One would predict that the aromatized compounds (+)-5 to (-)-8 
would be less stable than the unaromatized ones (-)-2 to (-)-4 due to the reduced 
aromaticity of their ferrocenyl units. However, we did not observe any obvious 
difference in their stabilities in the solid state as well in solution. Our attempts to 
obtain crystals of these ligands chelating to metal centers such as Cu(II), Co(II), 
and Ru(II) complexes for X-ray diffraction analysis have not been successful so 
far. 
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Scheme 3.2: Synthesis of ligands (+)-3 to (-)-8 
 
A significant advantage of using the FeCp group in ligands to control 
stereoselectivity of catalytic reactions is the ability to modulate its size. For 
example, the Cp group can be changed to Cp* (C5Me5) and CpPh5 (C5Ph5). With 
these more bulky groups, the apical positions of the catalytic center of the 
ferrosalen-metal complex may be shielded to varying degrees, which may only 
allow substrates to react through one specific pathway. In order to evaluate this, 
enantiopure (+)-9 and (-)-10 were synthesized (Scheme 3.3). For the synthesis of 
(+)-9, compound 16a83 was reacted with succinic anhydride in the presence of 
52 
 
AlCl3 to give the ferrocenyl ketone 17a. Reduction of the ketone with Zn/HgCl2 
resulted in compound 18a. Compound 18a was cyclized through an intramolecular 
Friedel-Crafts reaction using trifluoroacetic anhydride as the activation agent to 
give the racemic ferrocenyl cyclohexanone (±)-19a. To resolve the enantiomers, 
commercially available enantiopure (+)-20 was deprotonated with n-BuLi and the 
resulting anion reacted with ketone (±)-19a to give diastereoisomers 21xa and 
21ya. These isomers could be resolved on TLC with Rf values being 0.55 and 0.40, 
respectively, when the developing solvent mixture was hexanes/ether (1 : 1). 
However, we only obtained 21xa in pure form. During flash column 
chromatography, 21xa and 21yb slowly decomposed to give (+)-20, and the parent 
ketones (+)- and (-)-19a; the other diastereoisomer 21ya was contaminated with 
ketones and could not be purified. Pure 21xa was decomposed in refluxing toluene 
to give enantiopure (+)-19a.67,82 Formylation of (+)-19a with ethyl formate in the 
presence of sodium hydride gave (+)-22a, which was condensed with 1,2-
ethanediamine in anhydrous methanol to give ligand (+)-9. 
For the synthesis of (-)-10, compound 16b was prepared according to a 
modified literature procedure.84 This compound was converted to (±)-19b 
following the same sequence of reactions used for the preparation of (±)-19a. (±)-
19b was then resolved using (+)-20 according to the procedure described for 
resolution of (±)-19a. The two diastereoisomers 21xb and 21yb have Rf values of 
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0.35 and 0.20, respectively, when the developing solvent mixture was 
hexanes/ether (2 : 1). Similar to compounds 21xa and 21ya, these two 
diastereoisomers were not stable; they decompose slowly, resulting in (+)-20 and 
the parent ketones (+)- and (-)-19b. Because 21xb has a Rf value similar to that of 
ketone 19b, we were only able to obtain pure 21yb. Removal of the chiral 
auxiliary (+)-20 from 21yb in refluxing toluene gave enantiopure (-)-19b (Scheme 
3.3). At this time, we were not able to obtain enantiopure (+)-19b. With 
enantiopure (-)-19b in hand, the synthesis of (-)-10 was straightforward, even 
though the highly bulky FeCpPh5 group could have hindered the synthesis during 
the formylation and imine formation reactions. For formylation, compound (-)-22b 
was obtained in 77% yield. Condensation of (-)-22b with 1,2-ethanediamine gave 
ligand (-)-10 in 68% yield (Scheme 3.3). 
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Scheme 3.3: Synthesis of ligands (+)-9 and (-)-10 
All the ligands (-)-1 to (-)-10 were tested in the Co(III)-catalyzed carbonyl-
ene reaction (Equation 3.1a), Al(III)-catalyzed Strecker reaction (Equation 3.1b; 
for ease of isolation, the product was acylated with benzoyl chloride), and Al(III)-
catalyzed silylcyanation of aldehydes (Equation 3.1c). Under the conditions we 
have investigated, all reactions resulted in good yields but unsatisfactory 
enantioselectivity. The best selectivity we achieved for the carbonyl-ene reaction 
was 29% using (-)-8-Co(III) as the catalyst with a 5 mol % loading and with a     
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78% yield. The major enantiomer has an R configuration. Using (+)-7, a 
diastereoisomer of (-)-8, as the ligand, under the same conditions, the ee was 10% 
but the yield was higher at 99%. In this case, the major enantiomer had an S 
configuration. For the Strecker reaction, the best ee we obtained was 20%. The 
catalyst used was (-)-1-AlCl generated in situ with 10 mol % ligand and 9 mol % 
Et2AlCl. Under these conditions, the yield was quantitative. For the aldehyde 
silylcyanation reaction, the best ee was 26% in an 89% yield.  This was achieved 
using (+)-3-AlCl as the catalyst at a loading of 5 mol %. The configuration of the 
major enantiomer is S.85 With (+)-5-AlCl as catalyst and under similar conditions, 
the selectivity and yield were lowered to 18% ee and 84% respectively. We 
believe that the low ees obtained with ligands (-)-1 to (-)-10 can be attributed in 
part to the lack of steric hindrance at the 5 and 5′ positions. Without any bulky 
groups at these positions, a large area at the side opposite to the FeCp group is 
open. Assuming that there are no secondary interactions between the substrates 
and the catalysts, the conformations of the transition states are flexible. 
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Equation 3.1: Asymmetric reactions catalyzed by ferrosalen ligands (-)-1 to (-)-10 
 
In conclusion, we have synthesized and fully characterized nine 
enantiopure ferrosalen ligands and investigated their applications in 
enantioselective carbonyl-ene, Strecker, and silylcyanation of aldehyde reactions. 
All the ligands are compatible with these reaction conditions, and high yields were 
obtained. However, the enantioselectivity was low under the conditions we tested. 
The low selectivity may be a result of the lack of steric hindrance at the 5- and 5′-
positions of the ligands. Future work will be directed to the modulation of steric 
hindrance at these positions and to the evaluation of the resulting new ligands for 
catalytic enantioselective reactions. 
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Experimental Section 
General. All reactions were performed in oven-dried glassware under a 
nitrogen atmosphere using standard Schlenk techniques. Reagents and solvents 
available from commercial sources were used as received unless otherwise noted. 
THF was distilled from Na/benzophenone ketyl. MeOH, CH2Cl2, and toluene were 
distilled over CaH2. Thin-layer chromatography (TLC) was performed using plates 
with silica gel 60F-254 over glass support, 0.25 μm thickness. Flash column 
chromatography was performed using silica gel with a particle size of 32-63 μm. 
1H and 13C NMR spectra were measured at 400 MHz and 100 MHz, respectively; 
chemical shifts (δ) were reported in reference to solvent peaks (residue CHCl3 at δ 
7.24 ppm for 1H and CDCl3 at δ 77.00 ppm for 13C, C6D5H at δ 7.16 ppm for 1H 
and C6D6 at δ 128.4 ppm for 13C). GC-MS were measured on a Shimadzu GCMS-
QP5050A instrument: column, DB-5MS; thickness, 0.25 μm; diameter, 0.25 mm; 
length, 25m; MS, positive EI. HPLC was performed on a JASCO LC-2000Plus 
System: pump, PU-2089Plus Quaternary Gradient; detector, UV-2075Plus; chiral 
analytical column, Chiracel AS-H (5 μm diameter, 100 Å, 250 × 4.6 mm). All 
profiles were generated by detection of UV absorbance at 260 nm using a linear 
gradient solvent system: 1% to 10% 2-propanol in hexanes over 30 min at a flow 
rate of 1 mL/min. 
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Ferrosalen (-)-2. A solution of enantiopure (-)-11 (213 mg, 0.755 mmol) 
and 1,2-ethanediamine (22.7 mg, 0.378 mmol) in dry toluene (5 mL) was stirred 
under a nitrogen atmosphere at rt overnight. The solvent was removed under 
reduced pressure. Pure product (-)-2 was obtained as a red foam (222 mg, 0.376 
mmol, 100%): Rf = 0.1 (hexanes/CH2Cl2/Et3N 1 : 1 : 0.05); [α]21D = -308.2° (c = 
0.0036, CH2Cl2); 1H NMR (CDCl3) δ 9.54 (br s, 2H), 6.48 (s, 1H), 6.45 (s, 1H), 
4.67 (br s, 2H), 4.31 (t, J = 2.4 Hz, 2H), 4.23 (br s, 2H), 4.12 (s, 10H), 3.34-3.10 
(m, 4H), 2.94-2.82 (m, 2H), 2.39-2.02 (m, 6H); 13C NMR (CDCl3) δ 193.0, 149.8, 
101.8, 91.6, 78.7, 69.5, 69.2, 68.8, 63.8, 50.0, 28.5, 23.6; HRMS (FAB) m/z calcd 
for C32H32Fe2N2O2 [M]+ 588.1163, found 588.1160. 
Ferrosalen (+)-3. Following the procedure for the preparation of (-)-2, (+)-
11 (176 mg, 0.624 mmol) and (+)-13 (66.3 mg, 0.312 mmol) in MeOH (6 mL) 
were stirred at rt overnight. The product was purified with flash column 
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (+)-3 was obtained 
as a red foam (168 mg, 0.227 mmol, 73%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH 
1 : 1 : 0.03); [α]21D = +105.6° (c = 0.011, CH2Cl2); 1H NMR (CDCl3) δ 10.50 (br s, 
2H), 7.20-7.10 (m, 6H), 7.02-6.92 (m, 4H), 6.71 (s, 1H), 6.68 (s, 1H), 4.74 (br s, 
2H), 4.36 (t, J = 2.4 Hz, 2H), 4.28 (br s, 2H), 4.21 (s, 10H), 4.15 (s, 1H), 4.14 (s, 
1H), 3.10-2.98 (m, 2H), 2.47-2.16 (m, 6H); 13C NMR (CDCl3) δ 193.4, 148.7, 
138.4, 128.5, 127.7, 127.4, 102.7, 91.9, 78.9, 69.8, 69.6, 69.4, 69.0, 63.9, 28.8, 
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23.6; HRMS (ESI) m/z calcd for C44H40Fe2N2O2 [M+H]+ 741.1861, found 
741.1840. 
Ferrosalen (-)-4. Following the procedure for the preparation of (-)-2, (-)-
11 (359 mg, 1.27 mmol) and (+)-13 (108 mg, 0.508 mmol) in MeOH (15 mL) 
were stirred at rt overnight. The product was purified with flash column 
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-4 was obtained 
as a red foam (300 mg, 0.405 mmol, 80%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH 
1 : 1 : 0.03); [α]21D = -541.3° (c = 0.009, CH2Cl2); 1H NMR (CDCl3) δ 10.32 (br s, 
2H), 7.22-6.97 (m, 10H), 6.58 (s, 1H), 6.55 (s, 1H), 4.71 (br s, 2H), 4.33 (t, J = 2.4 
Hz, 2H), 4.21 (br s, 2H), 4.14 (s, 1H), 4.13 (s, 1H), 4.09 (s, 10H), 2.85-2.72 (m, 
2H), 2.26-2.09 (m, 4H), 1.92-1.79 (m, 2H); 13C NMR (CDCl3) δ 193.1, 148.3, 
138.1, 128.4, 127.6, 127.0, 102.5, 91.7, 78.8, 70.7, 69.6, 69.5, 69.3, 68.7, 63.7, 
28.3, 23.4; HRMS (ESI) m/z calcd for C44H40Fe2N2O2 [M+H]+ 741.1846, found 
741.1846. 
Ferrosalen (+)-5. Following the procedure for the preparation of (-)-2, (+)-
14 (107 mg, 0.382 mmol) and (+)-13 (36.9 mg, 0.174 mmol) in THF (5 mL) were 
stirred at rt for 10 h. The product was purified with flash column chromatography 
(SiO2, hexanes/EtOAc 2 : 3), and (+)-5 was obtained as a red foam (53 mg, 0.072 
mmol, 76%; recovered 54 mg of ferrocenyl aldehyde): Rf = 0.20 (SiO2, 
hexanes/EtOAc 2 : 3); [α]21D = +2380° (c = 0.002, CH2Cl2); 1H NMR (CDCl3) δ 
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7.41 (s, 1H), 7.38 (s, 1H), 7.23-7.08 (m, 10H), 6.28 (d, J = 8.8 Hz, 2H), 6.24 (d, J 
= 8.8 Hz, 2H), 5.11 (br s, 2H), 4.65 (br s, 2H), 4.61 (br s, 1H), 4.60 (br s, 1H), 4.34 
(t, J = 2.4 Hz, 2H), 3.98 (br s, 10H); 13C NMR (CDCl3) δ 191.7, 154.7, 136.8, 
129.1, 128.6, 127.5, 126.3, 113.8, 108.0, 89.4, 78.1, 71.2, 70.9, 70.5, 66.6, 64.5; 
HRMS (ESI) m/z calcd for C44H36Fe2N2O2 [M]+ 736.1470, found 736.1455. 
Ferrosalen (-)-6. Following the procedure for the preparation of (-)-2, (-)-
14 (96 mg, 0.343 mmol) and (+)-13 (33.1 mg, 0.156 mmol) in THF (5 mL) were 
stirred at rt for 10 h. The product was purified with flash column chromatography 
(SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-6 was obtained as a red foam (53 
mg, 0.072 mmol, 72%; 40 mg (-)-14 was recovered): Rf = 0.25 (SiO2, 
hexanes/Et2O/MeOH 1 : 1 : 0.03); [α]21D = -2635° (c = 0.003, CH2Cl2); 1H NMR 
(CDCl3) δ 7.30-7.09 (m, 12H), 6.12 (d, J = 9.2 Hz, 2H), 6.07 (d, J = 8.8 Hz, 2H), 
5.09 (br s, 2H), 4.62 (br s, 2H), 4.54 (br s, 1H), 4.52 (br s, 1H), 4.32 (t, J = 2.4 Hz, 
2H), 3.86 (s, 10H); 13C NMR (C6D6) δ 191.4, 154.3, 136.5, 128.8, 128.3, 127.2, 
125.9, 113.4, 108.0, 89.2, 77.8, 70.8, 70.0, 66.2, 64.1; HRMS (ESI) m/z calcd for 
C44H36Fe2N2O2 [M]+ 736.1470, found 736.1463. 
Ferrosalen (+)-7. Following the procedure for the preparation of (-)-2, (+)-
14 (275 mg, 0.983 mmol) and (-)-15 (56 mg, 0.492 mmol) in MeOH (10 mL) were 
stirred at rt overnight. The product was purified with flash column 
chromatography (SiO2, hexanes/Et2O/MeOH/Et3N 10 : 10 : 1 : 1), and (+)-7 was 
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obtained as a red foam (252 mg, 0.394 mmol, 80%): Rf = 0.20-0.25 (SiO2, 
hexanes/Et2O/MeOH/Et3N 10 : 10 : 1 : 1); [α]21D = +5605° (c = 0.005, CH2Cl2); 1H 
NMR (CDCl3) δ 7.25 (d, J = 11.2 Hz, 1H), 7.09 (d, J = 12.0 Hz, 1H), 6.22 (d, J = 
9.2 Hz, 1H), 6.18 (d, J = 9.2 Hz, 1H), 6.09 (d, J = 9.2 Hz, 1H), 6.01 (d, J = 9.2 Hz, 
1H), 5.07 (br s, 1H), 5.04 (br s, 1H), 4.63 (br s, 1H), 4.62 (br s, 1H), 4.32 (t, J = 
2.4 Hz, 1H), 4.30 (t, J = 2.4 Hz, 1H), 3.92 (s, 5H), 3.90 (s, 5H), 3.14-2.94 (m, 2H), 
2.31-2.10 (m, 2H), 1.96-1.76 (m, 2H), 1.66-1.28 (m, 4H); 13C NMR (CDCl3) δ 
191.5, 191.4, 155.2, 126.5, 126.4, 113.3, 113.1, 107.3, 107.0, 89.7, 89.5, 78.3, 
71.1, 70.9, 70.3, 70.2, 66.4, 66.2, 64.9, 64.6, 64.3, 64.1, 32.6, 32.3, 24.7, 24.5; 
HRMS (ESI) m/z calcd for C36H34Fe2N2O2 [M]+ 638.1314, found 638.1308. 
Ferrosalen (-)-8. Following the procedure for the preparation of (-)-2, (-)-
14 (404 mg, 1.443 mmol) and (-)-15 (82.4 mg, 0.722 mmol) in MeOH (15 mL) 
were stirred at rt overnight. The product was purified with flash column 
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-8 was obtained 
as a red foam (302 mg, 0.473 mmol, 65%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH 
1 : 1 : 0.03); [α]21D = -3861° (c = 0.007, CH2Cl2); 1H NMR (CDCl3) δ 7.23 (d, J = 
12.0 Hz, 1H), 7.06 (d, J = 12.0 Hz, 1H), 6.20 (d, J = 9.6 Hz, 1H), 6.15 (d, J = 9.2 
Hz, 1H), 6.07 (d, J = 9.2 Hz, 1H), 5.98 (d, J = 8.8 Hz, 1H), 5.04 (br s, 1H), 5.01 
(br s, 1H), 4.60 (br s, 1H), 4.58 (br s, 1H), 4.28 (t, J = 2.0 Hz, 1H), 4.26 (t, J = 1.6 
Hz, 1H), 3.89 (s, 5H), 3.85 (s, 5H), 3.09-2.92 (m, 2H), 2.24-1.20 (m, 8H); 13C 
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NMR (CDCl3) δ 191.1, 154.9, 126.2, 126.1, 112.9, 112.7, 106.9, 106.6, 89.4, 77.9, 
70.7, 70.5, 69.9, 69.8, 66.0, 65.9, 64.4, 64.1, 63.9, 63.7, 32.2, 32.0, 24.2, 24.1; 
HRMS (ESI) m/z calcd for [M]+ 638.1314, found 638.1302. 
Ferrosalen-Cu(II) complex (-)-12. A two-neck  round-bottom flask was 
charged with (-)-2 (33.6 mg, 0.057 mmol) and the solvent mixture EtOH/H2O (9 : 
1, 3.3 mL). Cupric acetate (11.44 mg, 0.057 mmol) was added under positive N2 
pressure. After the mixture was stirred at rt for 2 h, volatile components were 
removed under reduced pressure. The deep red mixture was suspended in EtOH (2 
mL) and poured onto a pad of Celite. The solid on the Celite was further washed 
with cold EtOH (1 mL × 2). Then, to the filter cake was added CH2Cl2 (3 mL). 
The red solid was dissolved and was filtered into a clean round-bottom flask. The 
Celite was further washed with CH2Cl2 (3 mL × 2). The combined red filtrate was 
evaporated under reduced pressure, giving compound (-)-12 as a red crystalline 
solid (28.0 mg, 75%): [α]22D = -1564.7° (c = 0.002, CH2Cl2); HRMS (ESI) m/z 
calcd for C32H30CuFe2N2O2 [M]+ 649.0302, found 649.0275. This compound is 
paramagnetic and was not characterized with NMR. The structure of this complex 
was further confirmed with single-crystal X-ray diffraction analysis. A crystal 
suitable for the analysis was grown by slowly diffusing pentane into a solution of 
(-)-12 in CH2Cl2 at rt. Crystal data collection and processing parameters are given 
in Table 1. All calculations were performed using the SHELXL-97 program suite86 
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under the GUI WinGX.87  The structures were solved by direct methods and 
successive interpretation of the difference Fourier maps, followed by full-matrix 
least-squares refinement. All non-hydrogen atoms were refined anisotropically. 
The contribution of the hydrogen atoms, in their calculated positions, was included 
in the refinement using a riding model.  Upon convergence, the final Fourier 
difference map of the X-ray structures showed no significant peaks.  All details of 
the structure solution and refinements are given in the Supporting Information 
(CIF data). As is evident in a packing diagram supplied as Supplementary material, 
the molecules are arranged so that the cyclopentadienyl ligands are involved in -
 stacking with opposite sides of the salen moiety.  These packing interactions 
may be responsible for the slight twist away from planarity of the salen ligand. 
Full listings of atomic coordinates, bond lengths and angles, and displacement 
parameters for all the structures have been deposited at the Cambridge 
Crystallographic Data Centre (deposition number: CCDC 816340). 
   
64 
 
Table 3.1 
Crystal Data, Data Collection, and Structure Refinement for (-)-12 
Empirical formula C32 H30 Cu Fe2 N2 O2 
Mr 649.83 
Crystal Syst  trigonal 
Space group P3121 (No.152) 
a, b, c / Å 11.314(3), 11.314(3), 17.897(4) 
V / Å3 1984.0(8) 
  / mm-1 1.913 
Dcalcd / gcm-3 1.632 
crystal size / mm 0.15 ×  0.25 ×  0.40 
Z 3 
T / K 291 
2max / deg 50 
total, unique no. of data;Rint 1471, 1353; 0.067 
no. params / restraints 177/0 
R1(I2(I)), wR2, Sa 0.0554, 0.1175, 1.08 
w = 
1/[2(Fo2)+(0.0384P)2+1.9441P]
where P=(Fo2+2Fc2)/3 
min. / max. resd. Dens / e/Ang3 -0.35, 0.42 
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Ferrocenyl Ketocarboxylic Acid 17a. An oven-dried two-neck round-
bottom flask was flushed with argon. AlCl3 (3.195 g, 23.96 mmol) and CH2Cl2 (30 
mL) were added. Compound 16a83 (5.113 g, 19.97 mmol) in CH2Cl2 (50 mL) was 
then added dropwise via a cannula. The solution turned dark brown. After addition, 
succinic anhydride (2.398 g, 23.96 mmol) was added under positive argon 
pressure. The mixture was stirred at rt overnight. The reaction flask was cooled 
with an ice bath. Ice water (80 mL) was added to the mixture slowly over about 5 
min. The contents were transferred to a separatory funnel. The organic and 
aqueous phases were separated. The organic phase was washed with water (50 mL 
× 3), dried over anhydrous Na2SO4, and filtered. Solvents were removed under 
reduced pressure. The residue was purified with flash column chromatography 
(SiO2, hexanes/Et2O/CH2Cl2 2 : 1 : 1), giving 17a as a red solid (5.23 g, 74%): Rf 
= 0.20 (SiO2, hexanes/Et2O/CH2Cl2 2 : 1 : 1); mp 135 ˚C (dec); 1H NMR (CDCl3) 
δ 4.24 (br s, 1H), 3.99 (br s, 2H), 2.90 (br s, 2H), 2.61 (br s, 2H), 1.76 (s, 15H); 
13C NMR (CDCl3) δ 202.7, 178.6, 81.5, 80.0, 76.5, 71.7, 35.4, 29.5, 10.6; HRMS 
(ESI) m/z calcd for C19H24FeO3 [M]+ 356.1080, found 356.1071. 
Ferrocenyl Carboxylic Acid 18a. To a two-neck  round-bottom flask 
containing 17a (3.80 g, 10.67 mmol) and toluene (100 mL) was added Zn dust 
(20.90 g, 319.6 mmol) and HgCl2 (1.94 g, 7.143 mmol) sequentially under positive 
argon pressure. The mixture was stirred vigorously while H2O (100 mL) and then 
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HCl (12.1 M, 100 mL) were added via syringe. After addition, the mixture was 
heated to reflux for about 3 h. TLC indicated that 17a was completely consumed. 
The reaction mixture was cooled to rt. Some solids were formed, which were 
removed by filtration. The mother liquor was transferred into a separation funnel. 
The aqueous phase was removed. The organic phase was washed with brine (80 
mL × 2), dried over anhydrous Na2SO4, and filtered. Solvents were evaporated 
under reduced pressure, giving pure 18a as a red solid (3.47 g, 95%): Rf = 0.45 
(short SiO2 column, hexanes/Et2O/CH2Cl2 2 : 1 : 1); mp 61-64 ˚C; 1H NMR 
(CDCl3) δ 3.69 (br s, 2H), 3.59 (br s, 2H), 2.40 (t, J = 7.2 Hz, 2H), 2.34 (t, J = 7.2 
Hz, 2H), 1.95 (s, 15H), 1.87-1.80 (m, 2H); 13C NMR (CDCl3) δ 180.2, 86.7, 79.8, 
71.6, 70.8, 33.5, 27.0, 26.5, 10.9; HRMS (ESI) m/z calcd for C19H26FeO2 [M]+ 
342.1288, found 342.1276. 
Racemic ferrocenocyclohexanone (±)-19a. A two-neck round-bottom 
flask was charged with 18a (3.470 g, 10.14 mmol) and CCl4 (100 mL), and 
wrapped with aluminum foil. The solution was bubbled with argon for 10 min. 
After the solution was cooled  to 0 °C, trifluoroacetic anhydride (5.60 mL, 40.30 
mmol) was added via a syringe. The mixture was stirred on an ice bath and 
allowed to warm to rt gradually. TLC indicated that the reaction was complete in 3 
h. The contents were transferred into a separatory funnel and partitioned between 
10% NaOH (120 mL) and CH2Cl2 (80 mL). The organic phase was washed with 
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brine (100 mL × 2), dried over anhydrous Na2SO4, and filtered. Volatiles were 
removed under reduced pressure. Purification with flash column chromatography 
(SiO2, hexanes/Et2O 2 : 1)  gave (±)-19a as a red solid (2.44 g, 74%): Rf = 0.30 
(SiO2, hexanes/Et2O 1 : 1); mp 102 ˚C; 1H NMR (C6D6) δ 4.28-4.26 (m, 1H), 3.63 
(t, J = 2.4 Hz, 1H), 3.58-3.56 (m, 1H), 2.28-2.20 ( m, 1H), 2.17-2.09 (m, 1H), 
2.04-1.77 (m, 4H), 1.56 (s, 15H); 13C NMR (C6D6) δ 201.2, 90.6, 80.6, 77.1, 75.6, 
73.7, 69.7, 39.5, 23.9, 21.7, 10.3; HRMS (ESI) m/z calcd for C19H24FeO [M]+ 
324.1182, found 324.1172. 
Enantiopure Ferrocenocyclohexanone (+)-19a. To a solution of (+)-(S)-
N,S-dimethyl-S-phenylsulfoximine (20, 2.80 g, 16.5 mmol) in dry THF (40 mL) at 
0 °C was added a solution of n-butyllithum in hexane (2.0 M, 8.30 mL). After it 
was stirred for 15 min at this temperature, the mixture was cooled to -78 °C. The 
racemic (±)-19a (2.44 g, 7.53 mmol) in dry THF (60 mL) was added via cannula 
dropwise over 10 min. The mixture was stirred for an additional 3 h while being 
warmed to -20 °C gradually. Saturated ammonium chloride (50 mL) was then 
added. The mixture was diluted with water (50 mL) and extracted with ether (50 
mL × 3). The ether phase was washed with brine (100 mL), dried over anhydrous 
Na2SO4, and concentrated to dryness under reduced pressure at rt. The two 
diastereoisomers 21xa and 21ya were not very stable; they lose their chiral 
auxiliary slowly even at rt. A quick separation with flash column chromatography 
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(SiO2, hexanes/Et2O 2 : 1) gave pure 21xa as indicated by TLC (Rf = 0.55, SiO2, 
hexanes/Et2O 1 : 1). However, 21ya was found to be contaminated with (±)-19a. 
Because 21ya and (±)-19a have similar Rf values (Rf = 0.45, SiO2, hexanes/Et2O 1 : 
1), attempts to separate them were not successful. The pure 21xa was dissolved in 
dry toluene (30 mL), and the solutions were heated to reflux for 12 h. After the 
solution was cooled to rt, volatiles were removed. The residue was purified with 
flash chromatography (SiO2, hexanes/Et2O 2 : 1). Enantiopure (+)-19a was 
obtained as a red solid (1.11 g, 91%): Rf = 0.45 (SiO2, hexanes/Et2O 1 : 1); mp 110 
˚C; [α]23D = +532˚ (c = 0.018, CH2Cl2); 1H NMR (C6D6) δ 4.32 (br s, 1H), 3.63 (t, 
J = 2.4 Hz, 1H), 3.56 (br s, 1H), 2.30-2.22 (m, 1H), 2.16-2.08 (m, 1H), 2.03-1.76 
(m, 4H), 1.57 (s, 15H); 13C NMR (C6D6) δ 201.2, 90.6, 80.6, 77.2, 75.5, 73.7, 69.8, 
39.5, 23.9, 21.7, 10.3; HRMS (ESI) m/z calcd for C19H24FeO [M]+ 324.1182, 
found 324.1173. The impure 21ya was also heated in toluene to give (-)-19a, 
which was contaminated with (+)-19a (totally 1.20 g). The chiral auxiliary 20 was 
recovered without losing any optical purity. The combined yield of 20 from 21xa 
and 21ya was 89% (2.50 g). 
Formylated Ferrocenocyclohexanone (+)-22a. In a two-neck round-
bottom flask was charged (+)-19a (124.0 mg, 0.380 mmol) and NaH (153.0 mg, 
3.82 mmol) under nitrogen. THF (15 mL) and ethyl formate (0.308 mL, 3.82 
mmol) were added via syringe sequentially.  The mixture was heated to reflux for 
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3 h. TLC indicated that the reaction was complete.  After the mixture was cooled 
to rt, water (30 mL) was added, and the contents were transferred into a separatory 
funnel.  The mixture was extracted with ether (15 mL × 3). The combined ether 
extracts were washed with brine (30 mL), dried over anhydrous Na2SO4, and 
concentrated under reduced pressure. Purification with flash column 
chromatography (SiO2, hexanes/Et2O 4 : 1) gave (+)-22a as a red solid (125.0 mg, 
93%): Rf = 0.60 (SiO2, hexanes/Et2O 1 : 1); mp 130 ˚C (dec); [α]23D = +659˚ (c = 
0.018, CH2Cl2); 1H NMR (C6D6) δ 7.21 (br s, 1H), 4.29 (m, 1H), 3.72 (t, J = 2.8Hz, 
1H), 3.58 (m, 1H), 2.33-2.23 (m, 1H), 2.12-1.92 (m, 4H), 1.54 (s, 15H); 13C NMR 
(C6D6) δ 195.4, 164.6, 109.2, 90.4, 81.2, 76.4, 74.2, 68.9, 24.6, 20.9, 10.3; HRMS 
(ESI) m/z calcd for C20H24FeO2 [M]+ 352.1131, found 352.1117. 
Ferrosalen (+)-9. Following the procedure for the preparation of (-)-2, (+)-
22a (122.0 mg, 0.345 mmol) and 1,2-ethanediamine (11.5 µL, 0.172 mmol) in 
MeOH (5 mL) were stirred at 50 ˚C for 2 h. The product was purified with flash 
column chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.08), and (+)-9 was 
obtained as a red solid (101 mg, 80%): Rf = 0.35 (SiO2, hexanes/Et2O/MeOH 1 : 1 : 
7.5%); mp 82˚C (dec); [α]23D = +120˚ (c = 0.015, CH2Cl2); 1H NMR (C6D6) δ 9.72 
(br s, 2H), 6.12 (s, 1H), 6.09 (s, 1H), 4.50 (br s, 2H), 3.70 (t, J = 2.4 Hz, 2H), 3.57 
(br s, 2H), 2.70-2.57 (m, 2H), 2.50-2.11 (m, 10H), 1.71 (s, 30H); 13C NMR (C6D6) 
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δ 192.3, 148.9, 102.3, 89.9, 80.5, 79.8, 74.7, 72.6, 69.0, 49.9, 28.5, 22.0, 10.5; 
HRMS (ESI) m/z calcd for C42H52Fe2N2O2 [M]+ 728.2733, found 728.2730. 
Ferrocene 16b. This compound was synthesized using a modified literature 
procedure.84 To a solution of 1-bromopentaphenylcyclopentadiene (132 mg, 0.25 
mmol) in benzene (5 mL) was added Fe(CO)5 (59.0 mg, 0.30 mmol) under 
nitrogen. The mixture was heated to reflux for 3 h. After the mixture was cooled to 
rt, a solution of CpNa (0.263 mL of 2.0 M in THF, 0.525 mmol) was added via 
syringe. The mixture was stirred at rt for 18 h. The resulting orange mixture was 
filtered through Celite. The filtrate was collected, and solvents were removed 
under reduced pressure. The orange residue was heated to 160 °C under vacuum 
for 3 h. After it was cooled to rt, the remaining mixture was suspended in toluene 
and filtered through Celite. The filtrate was collected, and solvents were removed. 
Purification by recrystallization in hot toluene gave 16b as a red crystalline solid 
(115 mg, 81%). 
Ferrocenyl Ketocarboxylic Acid 17b. Following a procedure similar to 
that for the preparation of 17a,  the reaction of 16b (1.882 g, 3.325 mmol), AlCl3 
(0.935 g, 7.012 mmol), and succinic anhydride (0.332 g, 3.323 mmol) in CH2Cl2 at 
reflux temperature in 24 h gave 17b as a red foam after purification with flash 
column chromatography (SiO2, hexanes/Et2O 1 : 1; 1.65 g, 75%): Rf  =  0.15 (SiO2, 
hexanes/Et2O 1 : 1); 1H NMR (CDCl3) δ 7.18-7.01 (m, 25H), 4.88 (br s, 2H), 4.50 
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(br s, 2H), 2.80 (t, J = 7.2 Hz, 2H), 2.39 (t, J = 7.2 Hz, 2H); 13C NMR (CDCl3) δ 
201.9, 178.3, 134.7, 132.1, 127.2, 126.6, 88.2, 83.1, 79.0, 74.8, 36.2, 27.9; HRMS 
(ESI) m/z calcd for C44H34FeO3 [M+H]+ 667.1936, found 667.1948. 
Ferrocenyl Carboxylic Acid 18b. Following a procedure similar to that 
for the preparation of 18a, the reduction of 17b (1.65 g, 2.477 mmol) with Zn dust 
(4.860 g, 74.31 mmol) and HgCl2 (0.450 g, 1.657 mmol) in toluene (20 mL), H2O 
(20 mL) and HCl (12.1 M, 20 mL) at reflux temperature in 24 h gave 18b as a red 
solid after purification with flash column chromatography (short SiO2 column, 
hexanes/Et2O 2 : 1; 1.35 g, 84%): Rf = 0.30 (SiO2, hexanes/Et2O 1 : 1); mp 192 ˚C; 
1H NMR (CDCl3) δ 7.15-7.01 (m, 25H), 4.15 (br s, 2H), 4.12 (br s, 2H), 2.30-2.18 
(m, 4H), 1.79-1.68 (m, 2H); 13C NMR (CDCl3) δ 179.1, 135.9, 132.4, 127.1, 126.1, 
90.5, 87.6, 75.0, 74.1, 33.2, 26.7, 26.5; HRMS (ESI) m/z calcd for C44H36FeO2 
[M]+ 652.2065, found 652.2075. The compound may decompose slowly at rt and 
storing at -20 °C is suggested. 
Racemic Ferrocenocyclohexanone (±)-19b. Following a procedure similar 
to that for the preparation of (±)-19a, cyclization of 18b (424.0 mg, 0.650 mmol) 
to give (±)-19b was achieved with trifluoroacetic anhydride (1.0 mL, 7.195 mmol) 
in CCl4 (15 mL) at 50 ˚C overnight. Purification with flash column 
chromatography (SiO2, hexanes/CH2Cl2/Et2O 20 : 20 : 1)  gave the product as a 
red solid (375.0 mg, 91%): Rf = 0.30 (hexanes/CH2Cl2/Et2O 20 : 20 : 1); mp 220 
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˚C (dec); 1H NMR (CDCl3) δ 7.16-6.98 (m, 25H), 4.84-4.82 (m, 1H), 4.45-4.43 (m, 
1H), 4.37 (t, J = 2.4 Hz, 1H), 2.65-2.55 (m, 1H), 2.44-2.28 (m, 3H), 2.02-1.94 (m, 
1H), 1.77-1.64 (m, 1H); 13C NMR (CDCl3) δ 203.9, 134.5, 132.2, 127.2, 126.5, 
94.4, 87.7, 78.4, 77.8, 77.2, 72.8, 39.5, 24.9, 21.8; HRMS (ESI) m/z calcd for 
C44H34FeO [M]+ 634.1965, found 634.1959. 
Enantiopure ferrocenocyclohexanone (-)-19b. Following a procedure 
similar to that for the resolution of (±)-19a, (±)-19b (437.0 mg, 0.688 mmol) was 
first converted to 21xb and 21yb using (+)-(S)-20 (349.0 mg, 2.065 mmol) and n-
butyllithum in hexane (2.0 M, 1.032 mL) in THF. Because the two 
diastereoisomers 21xb and 21yb slowly lose the chiral auxiliary even at rt, they 
were quickly separated with flash column chromatography (short SiO2 column, 
hexanes/CH2Cl2/EtOAc 20 : 10 : 1). TLC analysis indicated that 21xb was still 
contaminated with (±)-19b. Because their Rf values were very close (Rf = 0.35, 
SiO2, hexanes/Et2O 2 : 1), attempts to separate them were not successful. However, 
the other diastereoisomer 21yb, which had an Rf value of 0.20 (SiO2, 
hexanes/Et2O 2 : 1), was obtained in pure form. The solution of 21yb in dry 
toluene (10 mL) was then heated to reflux overnight. Enantiopure (-)-19b was 
obtained as a red solid (171 mg, 78%): Rf = 0.35 (SiO2, hexanes/CH2Cl2/EtOAc 
20 : 10 : 1); mp 220 ˚C (dec); [α]23D = -311˚ (c = 0.0095, CH2Cl2); 1H NMR 
(CDCl3) δ 7.17-6.96 (m, 25H), 4.83 (br s, 1H), 4.44 (br s, 1H), 4.38 (br s, 1H), 
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2.66-2.55 (m, 1H), 2.45-2.28 (m, 3H), 2.02-1.93 (m, 1H), 1.79-1.64 (m, 1H); 13C 
NMR (CDCl3) δ 204.0, 134.5, 132.2, 127.2, 126.5, 94.4, 87.7, 78.4, 77.8, 77.2, 
72.8, 39.5, 24.9, 21.8; HRMS (ESI) m/z calcd for C44H34FeO [M]+ 634.1965, 
found 634.1956. The impure 21xb was also heated in toluene to give (+)-19b, 
which was contaminated with (-)-19b (total 262 mg). The chiral auxiliary 20 was 
recovered without losing any optical purity. The combined yield of 20 from 21xb 
and 21yb was 86% (300 mg). 
Formylated Ferrocenocyclohexanone (-)-22b. A procedure similar to that 
for the synthesis of (+)-22a was followed. Compound (-)-19b 171.0 mg, 0.269 
mmol), NaH (214.0 mg, 5.380 mmol), and ethyl formate (0.434 mL, 5.380 mmol) 
in THF (20 mL) were heated to reflux overnight. After the mixture was cooled to 
rt, saturated NH4Cl (30 mL) was added. The mixture was extracted with EtOAc 
(15 mL × 2). The organic phase was washed with brine (30 mL), dried over 
anhydrous Na2SO4, and concentrated under reduced pressure. Purification by flash 
column chromatography (short SiO2 column, hexanes/CH2Cl2/EtOAc 40 : 10 : 1) 
gave (-)-22b as a red solid (138.0 mg, 77%). The product may decompose slowly 
on silica gel. Enantiopure (-)-22b: Rf = 0.25 (SiO2, hexanes/Et2O 5 : 1); mp 210 ˚C 
(dec); [α]22D = -197˚ (c = 0.009, CH2Cl2); 1H NMR (CDCl3) δ 7.50-7.43 (br s, 1H), 
7.20-6.96 (m, 25H), 4.86 (t, J = 2.0Hz, 1H), 4.42 (br s, 1H), 4.41 (br s, 1H), 2.68-
2.58 (m, 1H), 2.44-2.24 (m, 3H); 13C NMR (CDCl3) δ 194.7, 165.4, 134.6, 132.5, 
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127.4, 126.7, 111.1, 91.4, 88.3, 78.7, 78.4, 77.7, 73.2, 25.6, 21.4; HRMS (ESI) m/z 
calcd for C45H34FeO2 [M]+ 662.1914, found 662.1904. 
Ferrosalen (-)-10. Following the procedure for the preparation of (-)-2, (-)-
22b (40.0 mg, 0.0604 mmol) and 1,2-ethanediamine (1.68 μL, 0.0251 mmol) in 
MeOH (5 mL) were stirred at 50 ˚C for 24 h. Purification by flash column 
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.02) gave (-)-10 as a red solid 
(23.0 mg, 68%): Rf = 0.10 (SiO2, hexanes/Et2O 1 : 1); mp 124-127 ˚C; [α]22D = -
69˚ (c = 0.0225, CH2Cl2); 1H NMR (CDCl3) δ 9.38 (br s, 2H), 7.14-6.96 (m, 50H), 
6.46 (s, 1H), 6.43 (s, 1H), 4.75 (br s, 2H), 4.24 (br s, 4H), 3.32-3.20 (br s, 2H), 
3.14-3.00 (br s, 2H), 2.58-2.06 (m, 8H); 13C NMR (CDCl3) δ 192.0, 149.1, 135.2, 
132.7, 127.2, 126.3, 103.9, 91.3, 87.9, 82.0, 77.0, 76.6, 72.7, 50.4, 29.2, 22.2;  
HRMS (ESI) m/z calcd for C92H72Fe2N2O2 [M]+ 1348.4293, found 1348.4292; 
calcd for [M+H]+ 1349.4365, found 1349.4360. 
Enantioselective Carbonyl-ene Reaction Catalyzed with Ferrosalen-
Co(III) Complexes.88 Ligand (-)-8 is used as an example. In a round-bottom flask 
containing (-)-8 (190 mg, 0.298 mmol) and MeOH (10 mL) was added Co(OAc)2 • 
4H2O (74.2 mg, 0.298 mmol) in MeOH (5 mL) via a cannula. The mixture was 
stirred at rt for 1 h. The solvent was removed under reduced pressure on a rotary 
evaporator. The flask, which contained the residue, was then wrapped with 
aluminum foil. CH2Cl2 (15 mL) was added via syringe, which was followed by 
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addition of AgSbF6 (205 mg, 0.596 mmol). The mixture was stirred at rt overnight. 
The resulting black suspension was poured onto a pad of Celite, which was 
washed with CH2Cl2. The filtrate was discarded. The Celite pad was then washed 
with acetone. The filtrate was concentrated to dryness under reduced pressure to 
give the Co(III) complex. The compound was used directly as a catalyst for the 
carbonyl-ene reaction without further purification. Ethyl glyoxylate (50% in 
toluene; 250.9 mg, 1.23 mmol) was heated to reflux under nitrogen for 1 h to crack 
its dimer. After it was cooled to rt, the solution was added to a round-bottom flask 
containing (-)-8 -Co(III) (19.0 mg, 0.02 mmol) in dry toluene (3 mL). The mixture 
was stirred at rt for 10 min. α-Methylstyrene (48.2 mg, 0.41 mmol) was then 
added via syringe in one portion. The reaction was allowed to proceed at rt, and 
the progress was monitored with GC-MS. After 16 h, the mixture was passed 
through a pad of Celite, which was washed with CH2Cl2 (3 mL × 3).  Volatiles 
were removed under reduced pressure. The residue was purified with flash column 
chromatography (SiO2, hexanes/Et2O 4 : 1). The product 2388 was obtained as a 
colorless oil (70.0 mg, 78%). The ee was determined with chiral HPLC using the 
conditions described in the general experimental section. The enantiomers S-23 
and R-23 were eluted at 17.0 and 21.0 min, respectively. The ee was 29% with R-
23 being the major enantiomer. In addition to ligand (-)-8, all other ligands, 
including (-)-1, (-)-2, (+)-3, (-)-4, (+)-5, (-)-6, (+)-7, (+)-9, and (-)-10 were also 
76 
 
tested for the reaction. The yields ranged from 20% to 99%. The ees ranged from 
0% to 10%. 
Enantioselective Strecker Reaction Catalyzed with Ferrosalen-Al(III) 
Complexes.44 Ligand (-)-1 is used as an example. In a round-bottom flask 
containing ligand (-)-1 (18.0 mg, 0.031 mmol) and dry CH2Cl2 (5 mL) was added 
Et2AlCl (1.0 M solution in hexanes, 27.8 µL, 0.028 mmol) via syringe. The 
mixture was stirred at rt for 2 h under nitrogen. (E)-N-Butylideneprop-2-en-1-
amine (34.5 mg, 0.31 mmol) was added via syringe. After the mixture was cooled 
to -78 °C, a solution of TMSCN (62 µL, 0.456 mmol) in CH2Cl2 (2 mL) was 
added via a cannula dropwise. The reaction mixture was warmed to rt gradually 
over 12 h. Pyridine (2 mL) was added, which was followed by benzoyl chloride 
(0.5 mL). The mixture was stirred for 1 h. Solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography (SiO2, 
hexanes/Et2O 10 : 1 to 5 : 1) to give pure product 24 as a colorless oil (77.9 mg, 
100%).44 The ee was determined with chiral HPLC using the conditions described 
in the general experimental section. The enantiomers (-)-24 and (+)-24 were eluted 
at 19.1 and 20.0 min, respectively. The ee was 20% with (+)-24 being the major 
enantiomer.  In addition to ligand (-)-1, all other ligands, including (-)-2, (+)-3, (-)-
4, (+)-5, (-)-6, (+)-7, (-)-8, (+)-9, and (-)-10 were also tested for the reaction. The 
yields were all quantitative. The ees ranged from 0% to 18%. 
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Enantioselective Silylcyanation of an Aldehyde.62 Ligand (+)-3 is used as 
an example. In a round-bottom flask under nitrogen was charged (+)-3 (15.2 mg, 
0.0205 mmol) and CH2Cl2 (1 mL). Et2AlCl (20.5 uL of 1.0 M solution in hexanes, 
0.0205 mmol) was added via syringe. The mixture was stirred at rt for 5 h. Oct3PO 
(23.8 mg, 0.0616 mmol) in CH2Cl2 (1 mL) was then added via cannula. After the 
mixture was cooled to -20 °C, freshly distilled benzaldehyde (43.6 mg, 0.41 mmol) 
and trimethylsilylcyanide (136 μl, 1.025 mmol) were added via syringe 
sequentially. The reaction was allowed to proceed at -20 °C, monitored with GC-
MS, and found complete in 24 h. Volatiles were removed under reduced pressure. 
The residue was suspended in ether and passed through a 1-inch pad of silica gel 
to remove the catalyst. The filtrate was concentrated to dryness. Purification with 
flash column chromatography (SiO2, hexanes/Et2O 10 : 1) gave product 2562 as a 
colorless liquid (76.0 mg, 89%). The ee was determined with chiral HPLC using 
the conditions described in the general experimental section. The enantiomers S-
25 and R-25 were eluted at 4.9 and 6.0 min, respectively. The ee was 26% with R-
25 being the major enantiomer. In addition to ligand (+)-3, all other ligands, 
including (-)-1, (-)-2, (-)-4, (+)-5, (-)-6, (+)-7, (-)-8, (+)-9, and (-)-10 were also 
tested for the reaction. The yields ranged from 63% to 99%. The ees ranged from 
0% to 26%. 
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Chapter 4 
Applications of Chiral Ferrosalen Ligands in catalysis 
  
This chapter describes the applications of ferrosalen compounds (-)-1 to (-)-
10 (Figure 4.1) in the following catalytic reactions: enantioselective carbonyl-ene 
reaction, enantioselective Strecker-type reaction and enantioselective 
silylcyanation. 
 
Figure 4.1: Ferrosalen and Ferrosalen-type ligands used in asymmetric catalysis 
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4.1 Enantioselective Carbonyl-ene reaction 
4.1.1 Introduction 
An ene reaction can be broadly classified as an alkene (ene) component to 
react with a broad range of enophiles: alkenes, alkynes, allenes, carbonyls, imines, 
etc. In this case, a carbonyl-ene reaction refers to the reaction of an alkene with a 
carbonyl group. This type of reaction can be potentially used to build up a wide 
range of products. From the mechanism, it comes with an appealing advantage of 
atom efficiency: all of the atoms in the substrates end up in the product.89 The 
general mechanism is shown in Scheme 4.1.  
 
Scheme 4.1: General mechanism of an ene reaction  
 Theoretically, carbonyl-ene reaction can proceed without any catalysts. 
However, due to the high energy barrier, it often needs very high temperature to 
proceed. When a Lewis acid catalyst was used to activate the carbonyl group, the 
reaction could proceed at room temperature or even lower temperature. 
Enantioselective versions of this reaction started to draw attention of chemists 
since 1980s. The chiral element was transferred from the chiral catalyst to the 
substrate through the Lewis acid activation step (Scheme 4.2).    
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Scheme 4.2: Chirality transfer of enantioselective carbonyl-ene reaction 
 During the development of catalysts for enantioselective carbonyl-ene 
reaction, many effective ones have been discovered. For example, Ti-BINOL 
complexes by Nakai/Mikami,90-91 C-2 symmetric Cu-Box catalyst by Evans,92-93 
tridentate Cr(III)-Schiff base complexes by Jacobsen,94 and also the use of C-2 
symmetric metal-salen complexes (figure 4.2).88  
 
Figure 4.2: Example catalysts for enantioselective carbonyl-ene reaction 
 
4.1.2 Result and discussion 
  For the initial studies, we examined the reaction with racemic ferrosalen 
ligand (±)-11 and a known salen ligand 12 (Table 4.1). The catalysts were 
synthesized by the known procedure of stirring the specific salen ligand with 
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Co(OAc)2•4H2O in MeOH followed by hexafluoroantimonate adduct formation. 
The benchmark catalytic reactions were carried out in toluene at room temperature 
in the presence of 5 mol % of catalysts and excess of ethyl glyoxylate. In entry 1, 
Product (±)-15 was formed at 100% conversion and 1% ee. This experiment 
established the standard protocol for our studies; In entry 2, the enantioselectivity 
was compared to the literature (46% ee).88 This result confirmed that the HPLC 
analysis is effective and well-functioning. These two reactions were used as 
benchmark reactions to the enantioselective catalysis. 
Table 4.1 
 Benchmark carbonyl-ene reactions using (±)-11 and 12 
 
entry catalyst Time (h) Yield a (%) eeb (%) 
1 (±)-11 overnight 100 1 
2 12 overnight 100 65c 
a Conversion determined by GC-MS. Experimental details can be found on page 74. b 
Determined by chiral HPLC analysis using a Daicel Chiralcel AS-H column (program details 
see experimental section). c (-)-enantiomer predominates as determined by comparation with 
literature data. 
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After establishing the standard conditions, enantiopure ferrosalen ligands 
were tested (Figure 4.1 and Table 4.2). In entry 1, the reaction was carried out in 
an ice bath and slowly warmed up to room temperature. Poor yield was obtained 
and enantioselectivity was also low. Heating up the reaction did not help with the 
enantioselectivity either (entry 2). The best selectivity was obtained in entry 8 
using (-)-8 as ligand, which gave 29% ee with (-) isomer as the major product. 
Ligand (+)-7, which is a diastereoisomer of (-)-8, was also tested for the reaction. 
The configuration of the major enantiomer is (+). We also used ligands with the 
bulkier Cp* [(+)-9] and CpPh5 [(-)-10] for the reaction. Unfortunately no ee was 
found (entry 9 and 10). The reason could be the steric bulkiness on the ligands. 
The active site for the substrate activation may be blocked. Besides Co, Ru-
ferrosalen complexes were also tested as shown in entry 11 and 12, only 10% ee 
was found when (+)-3-Ru (III) was used.   
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Table 4.2 
Ferrosalen complex catalyzed enantioselective carbonyl-ene reaction 
entry liganda T (˚C) solvent yield (%) eeb (%) 
1 (-)-1 0 - rt PhMe 20c 5 
2 (-)-2 70 PhMe 43 3 
3 (+)-3 rt PhMe 42c 0 
4 (-)-4 rt PhMe 60c 0 
5 (+)-5 rt PhMe 81 0 
6  (‐)‐6  rt  PhMe  88  0 
7 (+)-7 rt PhMe 99 10 (+) 
8 (-)-8 rt PhMe 78 29 (-) 
9 (+)-9 rt PhMe 72 0 
10 (-)-10 rt PhMe 56 0 
11 (+)-3-Ru (III) rt CH2Cl2 65c 10(-) 
12 (-)-8-Ru (III)d rt PhMe/ CH2Cl2 
76 0 
a Experimental details can be found on page 74.  b Determined by chiral HPLC analysis using a 
Daicel Chiralcel AS-H column (program details see experimental section on page 74), Specific 
configurations determined by comparison with literature data. c Yield determined by GC-MS. d 
10% catalyst loading. 
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4.2 Enantioselective Strecker-type reaction 
4.2.1 Introduction 
The Strecker reaction is one of the most important and convenient methods 
for the synthesis of α-amino acids. In the reaction, α-aminonitriles are prepared by 
addition of hydrogen cyanide to an imine (Scheme 4.3), which can be hydrolyzed 
to give the desired amino acid. The substrates are very cheap because the imines 
can be readily prepared by the condensation of the corresponding aldehyde or 
ketone with amines.  
 
Scheme 4.3: General mechanism of enantioselective Strecker reaction 
Stereoselective Strecker synthesis has been well developed due to the 
importance of optically active α-amino acids in pharmaceutical industry.95 The 
most developed method is asymmetric induction by using imines which already 
bear chiral auxiliary groups.96-98 In late 1990s, the first catalytic enantioselective 
version of the reaction was reported. Since then many successful chiral metal 
catalysts have been discovered, which include aluminum, titanium, zirconium and 
lanthanoid complexes (Figure 4.3).  
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Figure 4.3: Known catalysts for enantioselective Strecker reaction 
 
4.2.2 Result and discussion 
We first optimized the reaction conditions using the racemic ligand (±)-19. 
Aluminum was chosen to be the metal atom of the Lewis acid catalyst. As 
compared to other salen-metal complexes, salen-AlCl is the most effective catalyst 
in both conversion and enantioselectivity according to literature.44 The catalyst 
was generated in situ by stirring (±)-1 (10 mol %) and diethyl aluminum chloride 
(9 mol %) in anhydrous CH2Cl2 before adding the substrates. The reaction was 
carried out at room temperature overnight then quenched with benzoyl chloride in 
pyridine to stabilize the amino group. It was found that the conversion was 100% 
based on the GC-MS analysis. HPLC analysis of the purified 18 shows the ratio of 
the two enantiomers is 1:1. This experiment provided a standard for the 
enantioselective version of the catalysis (Scheme 4.4). 
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Scheme 4.4: Benchmark catalytic Strecker reaction using (±)-1   
A series of ferrosalen ligands with different steric hindrance were tested for 
the enantioselectivities as shown in Table 4.3. Because 100% conversion was 
obtained in the benchmark reaction, it is possible that background reaction is 
taking place in which no catalyst participated in the transformation. According to 
the literature, the background reaction occur rapidly at room temperature, while it 
is extremely slow at -70 °C.44 To test the effect of temperature on the selectivity of 
the reaction, (-)-1 was used for the reaction at different temperatures (entries 1, 2, 
and 3 in Table 4.3). At room temperature, 4% ee was obtained (entry 1). When the 
reaction was started at 0 °C and then slowly warm up to room temperature, 8% ee 
was obtained (entry 2). When the reaction was carried out at -78 °C and allowed to 
warm up naturally during overnight, ee was increased to 20% (entry 3). The result 
agreed with the literature44 that low temperature (-78 °C) should be used to 
maximize ee. Under low temperature conditions, (-)-2 was found to have similar 
selectivity to (-)-1 (entry 4, 18% ee). In entries 11 and 12, pentamethyl and 
pentaphenyl substituted ligands (+)-9 and (-)-10 were tested. Interestingly, poor 
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enantioselectivities was obtained. To avoid errors, which may cause low ees, these 
reactions were repeated. Low ees were obtained again. The reason for the low 
selectivities in entries 11 and 12 might be because the substituted ligands were too 
bulky for the catalyst to coordinate with the imine, which prevented the catalyzed 
reaction, and the product formed was from the competing background reaction.  
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Table 4.3 
Ferrosalen complex catalyzed enantioselective Strecker reaction 
 
entry catalysta T (°C) time yieldb (%) eec (%) 
1 (-)-1 rt overnight 100 4 (+) 
2 (-)-1 0 – rt overnight 100 8 (+) 
3 (-)-1 -78 – rt overnight 100 20 (+) 
4 (-)-2 -78 – rt overnight  100  18 (+) 
5 (+)-3 -78 – rt overnight  100  10 (+) 
6 (-)-4 -78 – rt overnight  100  4 (+) 
7 (+)-5 -78 – rt overnight  100  0 
8 (-)-6 -78 – rt overnight 100 6 (+) 
9 (+)-7 -78 – rt overnight  100  8 (-) 
10 (-)-8 -78 – rt overnight  100  12 (+)  
11 (+)-9 -78 – rt overnight  100  0 
12 (-)-10 -78 – rt overnight  100  3 (+) 
a ligand: 10 mol %, Et2AlCl: 9 mol %. Experimental details can be found on page 76.   
b Determined by GC-MS. c Determined by chiral HPLC analysis using a Daicel Chiralcel AS-
H column (program details see experimental section on page 76), specific configuration was 
not identified.  
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4.3 Enantioselective silylcyanation reaction 
We also tested enantioselective silylcyanation reaction, a similar reaction to 
Strecker-type reaction. The reactions were carried out by reacting benzaldehyde 
with an excess of trimethylsilylcyanide (2.5 equiv.) using the optimized 
conditions.99-100 The results are shown in Table 4.4. Compared to the Strecker-type 
reaction, the enantioselectivities in the silylcyanation reaction were better 
controlled by the chiral ligands, possibly because there was no or if there was, 
slower background reaction. The best enantioselectivity obtained was 26% ee, 
with (+)-3 as ligand. Interestingly, using (-)-4, the diastereoisomer of (+)-3, 
product was obtained with the same (-) configuration (entry 4). The same (-) 
configurations were also observed on (+)-5 and (-)-6 (entry 5 and 6). The reason 
might be that the enantioselectivities for these reactions were predominantly 
controlled by the chiral diphenylethylenediamine backbone. Pentamethyl and 
pentaphenyl substituted ligands (+)-9 and (-)-10 were used in entry 9 and 10. 
However, very low enantioselectivities were obtained. 
 
 
 
 
91 
 
Table 4.4 
Ferrosalen complex catalyzed enantioselective silylcyanation reaction 
 
entry ligand T (˚C) time (h) yielda (%) eeb (%) 
1 (-)-1 -20 48 86 8 (+) 
2 (-)-2 -20 48 99 12 (+) 
3 (+)-3 -20 48 89 26 (-) 
4 (-)-4 -20 48 87 12 (-) 
5 (+)-5 -20 48 84 18 (-) 
6 (-)-6 -20 48 77 16 (-) 
7 (+)-7 -20 48 85 12 (+) 
8 (-)-8 -20 48 88 20 (-) 
9 (+)-9c -20 24 96 8 (-) 
10 (-)-10d -20 48 63 0 
a Isolated yield. Experimental details can be found on page 77.  b Determined by chiral HPLC 
analysis using a Daicel Chiralcel AS-H column (program details see experimental section on 
page 77), specific configuration determined by comparing the optical rotation data with the 
literature c  1 mol % ligand, 1 mol % Et2AlCl, 5 mol % Oct3PO. d 2.5 mol % ligand, 2.5 mol % 
Et2AlCl, 7.5 mol % Oct3PO.  
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4.4 Future directions 
For the reactions tested above, enantioselectivities were low. This low 
selectivity may be attributable to the reaction and the ligands. For the Strecker 
reaction, one possible reason for low enantioselectivity could be the background 
reaction, which competes with the catalyzed reaction. From the perspective of the 
ligand structure, one reason for the low selectivities could be the lack of steric 
hindrance at several open sites on our ligand framework. To solve this problem, 
we proposed two solutions to modify the ligand structure. 
The first solution for ligand modification is to change the backbone. By 
constructing the salen framework with a diamine backbone that bears more bulky 
groups might improve enantioselectivities. Scheme 4.5 lists the finished synthesis 
of two noncommercial available amines. Compound 21 was obtained with 36% 
overall yield in two steps. Compound 22 was synthesized by Grignard addition to 
cyanogen which was prepared by a known procedure. Although a low yield was 
obtained (23%), 22 was prepared on a gram scale. 
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 Scheme 4.5: Synthesis of steric hindered diamines 21 and 22 
Another solution is to increase steric hindrance on 5, 5′ positions (Figure 
4.4). This is a possible solution because most successful salen ligands have bulky 
groups such as tert-butyl or triisobutylsilyl groups on 3, 3′ and 5, 5′ positions 
(Figure 4.4a). Figure 4.4b shows the catalytic mechanism of ferrosalen-metal 
system. In this catalytic system, the substrate activation will occur in the way that 
the planar chiral ferrocenyl groups will block the nucleophilic approach from the 
site of 3′ to 5′ positions. The approach from the site of 3 to 5 positions will be 
favored because of less steric hindrance. However, it is possible that the open sites 
at the 5, 5′ positions could allow the approach of nucleophiles. In this case a good 
way to improve the ligand structure would be to insert bulky groups at the 5, 5′ 
positions. 
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Figure 4.4: Comparison of Jacobsen’s salen and ferrosalen framework  
To increase the steric hindrance at the 5, 5′ positions, a functional group 
needs to be inserted in the structural motif (+)-23 (Scheme 4.5). A synthetic route 
was designed, which could use our synthetic strategy described in Chapter 2. 
Starting with ester protected ferrocene derivative 27, 26 could be readily prepared 
by reductive amination. We have tested this reaction, and the results are promising. 
The methyl ester is then hydrolyzed and the acid is cyclized. Racemic 25 could be 
obtained. Resolution of 25 will be achieved using the same chiral resolution 
method we used in Chapter 2. After formylation of (+)-24 and aromatization, 
substituted ferrosalen motif (+)-23 could be synthesized, which contains the bulky 
tert-amino group.  
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Scheme 4.5: Retro-synthetic design for the optimized ferrosalen structural motif 
 
4.5 Experimental section 
HPLC conditions for enantioselective catalytic reactions: 
HPLC analysis of compounds 15, 18 and 19 were performed on a JASCO 
LC-2000Plus System: pump, PU-2089Plus Quaternary Gradient; detector UV-
2075Plus; chiral analytical column, Chiracel AS-H (5 μm diameter, 100 Å, 250 × 
4.6 mm). All profiles were generated by detection of UV absorbance at 260 nm 
using the linear gradient solvent system: 1% to 10% 2-propanol in hexanes over 
30 min at a flow rate of 1 mL/min. 
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Synthesis of steric hindered diamines 21 and 22: 
20: To a round bottom flask containing malononitrile (0.116g, 1.756 mmol), 
3,5-di-t-butylbenzyl bromide (1.089g, 3.846 mmol) and 30 mL THF was added t-
BuOK (0.432g, 3.846 mmol) under positive N2 pressure. This mixture was heated 
at 50 °C overnight. The mixture was filtered through a celite pad using CH2Cl2, 
the filtrate was evaporated, and the residue was purified by flash column 
chromatography (SiO2, hexanes/Et2O 50:1) to give 20 as colorless oil (0.740g, 90% 
yield). 1H NMR (CDCl3) δ 7.58 (s, 2H), 7.39 (s, 4H), 3.37 (s, 4H), 1.49 (s, 36H); 
13C NMR (CDCl3) δ 151.2, 131.3, 124.6, 122.3, 115.1, 44.1, 41.8, 34.8, 31.6. 
21: A N2 filled round-bottom flask containing 20 (1.072g, 2.280 mmol) and 
20 mL Et2O was cooled with an ice bath. Lithium aluminumhydride (0.260g, 
6.830 mmol) was added in 3 portions under positive N2 flow. The reaction mixture 
was allowed to warm up to rt naturally and stirred overnight. The reaction mixture 
was cooled with an ice bath, 0.27 mL H2O, 0.26 mL 15% NaOH, 0.78 mL H2O 
were added sequentially in 15 min. The mixture was stirred for additional 15 min 
and was filtered through a celite pad using Et2O. The filtrate was collected and the 
solvent was removed under reduced pressure. Purification by flash column 
chromatography (SiO2, hexanes/Et2O/Et3N 50:50:5) gave 21 as a light yellow oil 
(0.450g, 41% yield). 1H NMR (C6D6) δ 7.36 (s, 2H), 7.25 (s, 4H), 2.78 (s, 4H), 
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2.50 (s, 4H), 1.28 (s, 36H), 0.76 (br s, 4H); 13C NMR (C6D6) δ 150.2, 138.5, 125.3, 
119.6, 45.6, 44.1, 41.1, 34.7, 31.6, 31.5. 
22: Cyanogen was freshly prepared according to the literature procedure 
and stored under -78 °C. 101 A two-neck  round bottom flask containing cyanogen 
(1.107g, 6.431 mmol) and 15 mL Et2O was cooled down to -78 °C, 
benzylmagnesium chloride (25.6 mL, 51.2 mmol) was added dropwise. The 
mixture was warmed up to rt in 45 min and was allowed to stir for additional 30 
min. Titanium isopropoxide  (5.6 mL, 19.11 mmol) was added dropwise and the 
mixture was stirred at rt overnight. The mixture was cooled in an ice bath, and 100 
mL aqueous NaOH (10%) was added dropwise. The mixture was vacuum filtered 
and the filtrate was partitioned between EtOAc and aqueous NaOH (10%). The 
organic phase was washed with brine (80 mL), dried over anhydrous Na2SO4, and 
filtered. The solvent was removed under reduced pressure. Purification by flash 
column chromatography (SiO2, hexanes/EtOAc 5:1) gave 22 as a light yellow oil 
(0.622g, 23% yield). 1H NMR (CDCl3) δ 7.42-7.22 (m, 20H), 4.68 (s, 8H), 1.78 
(br s, 4H); 13C NMR (CDCl3) δ 140.8, 128.5, 127.6, 127.0, 65.3. 
  
98 
 
Conclusions 
The requirement of enantiopure compounds for clinical applications has led 
to significant progress in developing transition-metal catalyzed reactions in the 
past decades. Due to the fact that most catalysts consist of a metal and one or more 
chiral ligands, the development of chiral ligands that can offer high yields and 
enantioselectivity are in a high demand. Although numerous discoveries have been 
made in this area, most of the successful ligands are the result of hundreds of 
failures and extensive optimizations. 
In this dissertation, we have successfully designed and synthesized a new 
chiral ferrosalen ligand framework. These ligands were synthesized 
stereoselectively using a highly effective chiral auxiliary approach. The method is 
inexpensive and atom-economic. More sterically hindered ligand derivatives were 
also synthesized with pentamethyl and pentaphenyl substituted ferrocene as the 
starting materials. The structure of the ligand was confirmed by X-ray 
crystallography study of one of the ligand-Cu(II) complex. The ligands have 
unique structural features, thus they may find wide applications in asymmetric 
catalysis.  
We also explored the catalytic activities of these ferrosalen ligands in 3 
asymmetric catalytic reactions: enantioselective carbonyl-ene reaction, 
enantioselective Strecker-type reaction and enantioselective silylcyanation. The 
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catalytic reactions were carried out with good chemical yield (up to 99%), and 
enantioselectivities of up to 29% for the carbonyl-ene reaction, 20% for the 
Strecker reaction and 26% for the silylcyanation reaction were observed. Although 
the enantioselectivities are far from achieving the goal as successful chiral ligands, 
it is encouraging that the ligands are configurationally stable and the structures can 
be easily optimized for better tuning the catalytic activities.  
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Stereoselective Synthesis of a Chiral Ferrosalen Ligand Using 
an Aromatization Strategy 
Xiang Zhang, Rudy L. Luck, Shiyue Fang 
 
Supplemental Information 
Compound numbers correspond to the numbers in the article: Xiang Zhang, Rudy 
L. Luck, Shiyue Fang. Journal of Organometallic Chemistry, 2010, in press. The 
article is in Chapter 2 of the dissertation. 
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A.1 General Experimental 
 
All reactions were performed in oven-dried glassware under a nitrogen 
atmosphere using standard Schlenk techniques. Reagents and solvents available from 
commercial sources were used as received unless otherwise noted. THF was distilled 
from Na/benzophenone ketyl. MeOH was distilled over CaH2. Thin layer 
chromatography (TLC) was performed using plates with silica gel 60F-254 over glass 
support, 0.25 μm thickness. Flash column chromatography was performed using silica gel 
with particle size of 32-63 μm. 1H and 13C NMR spectra were measured at 400 MHz and 
100 MHz, respectively; chemical shifts (δ) were reported in reference to solvent peaks 
(residue CHCl3 at δ 7.24 ppm for 1H and CDCl3 at δ 77.00 ppm for 13C). 
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A.2 1H and 13C NMR spectra of new compounds
 
Figure A.1: 1H NMR spectrum of 7 
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Figure A.2: 13C NMR spectrum of 7 
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Figure A.3: 1H NMR spectrum of 10 
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Figure A.4: 13C NMR spectrum of 10 
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 Figure A.6: 13C NMR spectrum of 11a 
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 Figure A.7: 1H NMR spectrum of 11b 
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 Figure A.8: 13C NMR spectrum of 11b 
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  Figure A.10: 13C NMR spectrum of 11c 
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Figure A.11: 1H NMR spectrum of 9 
Fe
C
p O
H
H
O
9
1 H
N
M
R
sp
ec
tru
m
of
9
in
C
D
C
l 3
1
2
3
4
56
7
7a 3a
129 
 
 
Figure A.12: 13C NMR spectrum of 9 
  
 Figure A.13: 1H NMR spectrum of 12 
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Figure A.14: 13C NMR
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Figure A.15: 1H NMR spectrum of 3 
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Figure A.16: 13C NMR spectrum of 3 
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A.3 X-ray crystal structure of compound 12  
 
 
Figure A.17: X-ray crystal structure of compound 12 
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Appendix B 
Supporting Information for Chapter 3 
 
 
Ferrosalen and Ferrosalen-type Ligands: Structural Modulation 
and Applications in Asymmetric Catalysis 
Xiang Zhang, Rudy L. Luck, Shiyue Fang 
 
Supplemental Information 
(Compound numbers correspond to the numbers in the article: Zhang, Xiang; Luck, 
Rudy; Fang, Shiyue. Organometallics, 2011, accepted for publication. This article 
is in Chapter 3 of the dissertation.) 
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B.1 1H and 13C NMR spectra of new compounds
 
Figure B.1: 1H NMR spectrum of (-)-1 
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Figure B.2: 13C NMR spectrum of (-)-1 
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Figure B.3: 1H NMR spectrum of (-)-2 
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Figure B.4: 13C NMR spectrum of (-)-2 
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Figure B.5: 1H NMR spectrum of (+)-3 
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Figure B.6: 13C NMR spectrum of (+)-3 
143 
 
 
Figure B.7: 1H NMR spectrum of (-)-4 
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Figure B.8: 13C NMR spectrum of (-)-4 
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Figure B.9: 1H NMR spectrum of (+)-5 
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Figure B.10: 13C NMR spectrum of (+)-5 
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Figure B.11: 1H NMR spectrum of (-)-6 
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Figure B.12: 13C NMR spectrum of (-)-6 
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Figure B.13: 1H NMR spectrum of (+)-7 
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Figure B.14: 13C NMR spectrum of (+)-7 
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Figure B.15: 1H NMR spectrum of (-)-8 
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Figure B.16: 13C NMR spectrum of (-)-8 
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Figure B.17: 1H NMR spectrum of 17a 
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Figure B.18: 13C NMR spectrum of 17a 
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Figure B.19: 1H NMR spectrum of 18a 
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Figure B.20: 13C NMR spectrum of 18a 
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Figure B.21: 1H NMR spectrum of (±)-19a 
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Figure B.22: 13C NMR spectrum of (±)-19a 
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Figure B.23: 1H NMR spectrum of (+)-19a 
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Figure B.24: 13C NMR spectrum of (+)-19a 
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Figure B.25: 1H NMR spectrum of (+)-22a 
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Figure B.26: 13C NMR spectrum of (+)-22a 
13
C
N
M
R
sp
ec
tru
m
of
(+
)-
22
a
in
C
6D
6
Fe
C
p*
O
H
O
(+
)-2
2a
163 
 
 
Figure B.27: 1H NMR spectrum of (+)-9 
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Figure B.28: 13C NMR spectrum of (+)-9 
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Figure B.29: 1H NMR spectrum of 17b 
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Figure B.30: 13C NMR spectrum of 17b 
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Figure B.31: 1H NMR spectrum of 18b 
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Figure B.32: 13C NMR spectrum of 18b 
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Figure B.33: 1H NMR spectrum of (±)-19b 
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Figure B.34: 13C NMR spectrum of (±)-19b 
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Figure B.35: 1H NMR spectrum of (-)-19b 
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Figure B.36: 13C NMR spectrum of (-)-19b 
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Figure B.37: 1H NMR spectrum of (-)-22b 
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Figure B.38: 13C NMR spectrum of (-)-22b 
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Figure B.39: 1H NMR spectrum of (-)-10 
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Figure B.40: 13C NMR spectrum of (-)-10 
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B.2 High resolution MS spectra of new compounds 
  
Figure B.41: High resolution MS for (-)-2 
  
Figure B.42: High resolution MS for (+)-3 
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Figure B.43: High resolution MS for (-)-4 
 
Figure B.44: High resolution MS for (+)-5 
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Figure B.45: High resolution MS for (-)-6 
 
Figure B.46: High resolution MS for (+)-7 
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Figure B.47: High resolution MS for (-)-8 
 
Figure B.48: High resolution MS for (+)-9 
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Figure B.49: High resolution MS for (-)-10 
 
 
Figure B.50: High resolution MS for (-)-12 
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Figure B.51: High resolution MS for 17a 
 
Figure B.52: High resolution MS for 18a 
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Figure B.53: High resolution MS for (±)-19a 
 
Figure B.54: High resolution MS for (+)-19a 
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Figure B.55: High resolution MS for (+)-22a 
 
 
Figure B.56: High resolution MS for 17b 
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Figure B.57: High resolution MS for 18b 
 
 
Figure B.58: High resolution MS for (±)-19b 
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Figure B.59: High resolution MS for (-)-19b 
 
Figure B.60: High resolution MS for (-)-22b 
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Appendix C 
Supporting Information for Chapter 4 
 
 
Applications of Chiral Ferrosalen Ligands in catalysis 
 
(Compound numbers correspond to the numbers in Chapter 4 of the dissertation.) 
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C.1 Chiral HPLC profiles 
Carbonyl-ene Reaction: Chiral HPLC profiles of 15: 
  
 Ratio of enantiomers: 49:51 
 
Figure C.1: HPLC profile for 15 using (±)-11-Co(III) as the catalyst  
 
 Ratio of enantiomers: 17:83 
 
Figure C.2: HPLC profile for 15 using 12-Co(III) as the catalyst 
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 Ratio of enantiomers: 55:45 
 
Figure C.3: HPLC profile for 15 using (+)-7-Co(III) as the catalyst 
 
 
 Ratio of enantiomers: 36:64 
 
Figure C.4: HPLC profile for 15 using (-)-8-Co(III) as the catalyst 
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Strecker-type Reaction: Chiral HPLC profiles of 18 
 Ratio of enantiomers: 46:50 
 
Figure C.5: HPLC profile for 18 using (-)-1-AlCl as the catalyst (rt) 
 
 
 Ratio of enantiomers: 42:51 
 
Figure C.6: HPLC profile for 18 using (-)-1-AlCl as the catalyst (0 °C - rt) 
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Ratio of enantiomers: 39:61 
 
Figure C.7: HPLC profile for 18 using (-)-1-AlCl as the catalyst (-78 °C - rt)   
 Ratio of enantiomers: 41:59 
 
Figure C.8: HPLC profile for 18 using (-)-2-AlCl as the catalyst 
 Ratio of enantiomers: 45:55 
 
Figure C.9: HPLC profile for 18 using (+)-3-AlCl as the catalyst 
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 Ratio of enantiomers: 48:52 
 
Figure C.10: HPLC profile for 18 using (-)-4-AlCl as the catalyst 
 Ratio of enantiomers: 50:50 
 
Figure C.11: HPLC profile for 18 using (+)-5-AlCl as the catalyst 
 Ratio of enantiomers: 47:53 
 
Figure C.12: HPLC profile for 18 using (-)-6-AlCl as the catalyst 
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 Ratio of enantiomers: 54:46 
 
Figure C.13: HPLC profile for 18 using (+)-7-AlCl as the catalyst 
 Ratio of enantiomers: 44:56 
 
Figure C.14: HPLC profile for 18 using (-)-8-AlCl as the catalyst 
 Ratio of enantiomers: 43:46 
 
Figure C.15: HPLC profile for 18 using (-)-10-AlCl as the catalyst 
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Silylcyanation Reaction: Chiral HPLC profiles of 19 
 Ratio of enantiomers: 46:54 
 
Figure C.16: HPLC profile for 19 using (-)-1-AlCl as the catalyst 
 
 Ratio of enantiomers: 44:56 
 
Figure C.17: HPLC profile for 19 using (-)-2-AlCl as the catalyst 
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Ratio of enantiomers: 63:37 
 
Figure C.18: HPLC profile for 19 using (+)-3-AlCl as the catalyst 
 Ratio of enantiomers: 56:44 
 
Figure C.19: HPLC profile for 19 using (-)-4-AlCl as the catalyst 
 Ratio of enantiomers: 59:41 
 
Figure C.20: HPLC profile for 19 using (+)-5-AlCl as the catalyst 
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 Ratio of enantiomers: 58:42 
 
Figure C.21: HPLC profile for 19 using (-)-6-AlCl as the catalyst 
 Ratio of enantiomers: 44:56 
 
Figure C.22: HPLC profile for 19 using (+)-7-AlCl as the catalyst 
 Ratio of enantiomers: 60:40 
 
Figure C.23: HPLC profile for 19 using (-)-8-AlCl as the catalyst 
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 Ratio of enantiomers: 54:46 
 
Figure C.24: HPLC profile for 19 using (+)-9-AlCl as the catalyst: 
 
 Ratio of enantiomers: 51:49 
 
Figure C.25: HPLC profile for 19 using (-)-10-AlCl as the catalyst: 
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C.2 1H and 13C NMR spectra of new compounds
 
Figure C.26: 1H NMR spectrum of 20 
200 
 
 
Figure C.27: 13C NMR spectrum of 20 
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Figure C.28: 1H NMR spectrum of 21 
   
202 
 
 
Figure C.29: 13C NMR spectrum of 21 
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Figure C.30: 1H NMR spectrum of 22 
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Figure C.31: 13C NMR spectrum of 22 
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